Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 1mo ago Cron last ran Mar 30, 13:54 1mo ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-10-24 22:02 6mo ago
2025-10-24 17:49 6mo ago
PNC Financial Services Group: A Resilient Performance stocknewsapi
PNC
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-24 22:02 6mo ago
2025-10-24 17:50 6mo ago
Electric Metals (USA) Limited Closes $4 Million Non-Brokered Private Placement stocknewsapi
EMUSF
Led by Eric Sprott and Crescat Capital VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / Electric Metals (USA) Limited ("EML" or the "Company") (TSXV:EML)(OTCQB:EMUSF) is pleased to announce the closing of its previously announced non-brokered private placement, raising gross proceeds of approximately C$4 million. The financing, led by Eric Sprott and Crescat Capital, will advance the Company's North Star Manganese Project in Minnesota, supporting a critical U.S. domestic supply of high-purity manganese products, including high-purity manganese sulfate monohydrate (HPMSM), for the U.S. electric vehicle battery and energy sector.
2025-10-24 22:02 6mo ago
2025-10-24 17:52 6mo ago
Microsoft's Xbox to Remake Original Halo Video Game stocknewsapi
MSFT
The remake, titled Halo: Campaign Evolved, will support multiplayer gaming across several consoles for the first time.
2025-10-24 22:02 6mo ago
2025-10-24 17:52 6mo ago
US debt accelerates through $38 trillion: Has gold peaked? stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.
2025-10-24 22:02 6mo ago
2025-10-24 17:55 6mo ago
Pennant Announces Third Quarter 2025 Earnings Release and Call stocknewsapi
PNTG
October 24, 2025 17:55 ET

 | Source:

Pennant Group, Inc.

EAGLE, Idaho, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its third quarter 2025 financial results on Wednesday, November 5, 2025.

Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, November 6, 2025, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during which Pennant’s management will discuss its third quarter results.

To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investor Relations section of our website at http://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website until 5:00 p.m. Mountain Time on November 6, 2026.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. More information about Pennant is available at www.pennantgroup.com.

Contact

The Pennant Group, Inc.
(208) 401-1400
[email protected]

SOURCE: The Pennant Group, Inc.
2025-10-24 22:02 6mo ago
2025-10-24 17:55 6mo ago
U.S. Regulator Probes Tesla's ‘Mad Max' Mode Over Safety Concerns stocknewsapi
TSLA
ToplineThe National Highway Traffic Safety Administration is reportedly looking into Tesla’s new “Mad Max” driver-assistance mode over concerns that it allows vehicles to operate at higher speeds above posted speed limits, reports Reuters as billionaire Elon Musk’s car company continues to draw scrutiny.

VAIL, CO - JUNE 9, 2017: The Tesla brand logo embellishes the nose of a Tesla electric sedan in Vail, Colorado. (Photo by Robert Alexander/Getty Images)

Getty Images

Key FactsNHTSA's latest inquiry comes at the same time the agency is examining more than 50 reports of traffic-safety violations and several crashes involving Tesla’s Full Self-Driving system, which is installed in roughly 2.9 million vehicles, according to Reuters.

The Department of Transportation said earlier this month it documented 58 incidents involving Tesla vehicles using FSD, including 14 crashes and 23 injuries, linked to red-light violations and vehicles driving against the proper direction of travel on public roadways.

Descriptions of Tesla’s “Mad Max” mode — one mode of the FSD system — cite faster speeds and more frequent lane changes than other FSD modes, according to Insurance Business.

Tesla has not publicly commented directly on the new inquiry, though the company noted on X that in the third quarter of 2025 it recorded one crash for every 6.36 million miles driven with Autopilot engaged, compared with one crash every 720,000 miles across all U.S. vehicles based on NHTSA data in 2023.

Crucial QuoteIn a post on X reposted by Tesla, Nick Cruz Patane says: “Mad Max mode is INSANE. It drives your car like a sports car. If you are running late, this is the mode for you.”

Key BackgroundTesla’s automation systems have long drawn regulatory scrutiny. In 2022, regulators warned that a feature allowing vehicles to move through all-way stop intersections without fully stopping could raise the risk of crashes. In response, the company issued a recall, affecting more than 50,000 vehicles, and released a free over-the-air update to deactivate the “rolling-stop” software. Most recently, “Mad Max” has reignited concerns about Tesla’s software practices, as the company faces overlapping probes from agencies including NHTSA and the California Department of Motor Vehicles over how Tesla promotes its Autopilot and FSD systems, Insurance Business reports.

Further ReadingTesla under scrutiny as it slips out 'Mad Max' driving mode
2025-10-24 22:02 6mo ago
2025-10-24 17:55 6mo ago
Wabtec: Executing Despite Softer Organic Growth stocknewsapi
WAB
Westinghouse Air Brake Technologies Corporation, aka Wabtec, continues to deliver strong operating performance, combining sales growth, margin expansion, and strategic M&A to drive long-term value. Recent acquisitions, including Evident's Inspection Technologies and Frauscher Sensor Technology, boost high-margin revenue and support a clear path to $10 earnings per WAB share by 2026/2027. Despite near-term headwinds from lower North American railcar deliveries, WAB's resilient organic performance and robust backlog underpin solid growth prospects.
2025-10-24 22:02 6mo ago
2025-10-24 17:56 6mo ago
SentinelOne: Expensive Today, Cheap Tomorrow If Growth Delivers stocknewsapi
S
SummarySentinelOne is rated a Buy with a $23 price target, reflecting 33% upside potential driven by robust AI-powered cybersecurity demand.S reported a strong FQ2 2026, delivering double-digit revenue and EPS growth, beating analyst expectations and reaching $1 billion in annual recurring revenue.Management highlights leadership in AI-security, expanding platform offerings, and impressive triple-digit growth in Purple AI, justifying S's premium valuation.With the cybersecurity market set to double by 2030, S is well-positioned for continued growth, making it a compelling opportunity for investors seeking sector exposure. JuSun/iStock via Getty Images

SentinelOne, Inc. (NYSE:S) is an American cybersecurity company that provides AI-tailored security services for computers, servers, cloud workloads, IoT devices, and other endpoints. It operates under its autonomous cybersecurity platform named Singularity XDR

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in S over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You
2025-10-24 22:02 6mo ago
2025-10-24 18:00 6mo ago
Scope Technologies Announces $3 Million Private Placement Financing stocknewsapi
SCPCF
October 24, 2025 6:00 PM EDT | Source: Scope Technologies Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2025) - Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies" or the "Company") today announced a non-brokered private placement financing of 7,894,737 units ("Units") at a price of $0.38 per Unit for gross proceeds of $3,000,000 (the "Offering").

Each Unit under the Offering will consist of one common share and one-half of one share purchase warrant (each whole warrant, a "Warrant"), with each Warrant entitling the holder to purchase one additional share at a price of $0.60 per share for a period of three years from the date of issue.

All securities issued under the Offering, including securities issuable on the exercise thereof, are subject to a hold period expiring four months and one day from the date of issuance. The Company may pay finders fees in relation to this the Offering.

The proceeds of the Offering will be used to further expand the Company’s QSE platform and for general working capital requirements.

"This funding allows Scope Technologies to grow and support ongoing operations," said Ted Carefoot, CEO of Scope Technologies Corp. "Accelerating our goal to make QSE a go to post-quantum security preparedness and encryption company."

For more information on how your company can integrate QSE quantum security solutions for their business, visit www.qse.group or contact [email protected].

About Scope Technologies Corp.

Headquartered in Vancouver, British Columbia, Scope Technologies Corp. is a leader in quantum-secure infrastructure, specializing in protecting sensitive data with innovations in post-quantum storage and authentication. Through QSE Group, Scope is developing solutions to meet the growing enterprise demand for cryptographic resilience, allowing organizations to secure scalable technology that drives growth and operational efficiency to safeguard critical systems today while preparing for the quantum era.

LinkedIn: scope-technologies-corp
Facebook: Scope Technologies Corp
Twitter: @ScopeTechCorp

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's latest management discussion and analysis, a copy of which is available under the Company's profile on SEDAR+ at www.sedarplus.ca. While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company's business. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.

The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271912
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
Rivalry Announces Closing of Private Placement and Debt Restructuring stocknewsapi
RVLCF
October 24, 2025 16:30 ET

 | Source:

Rivalry Corp.

TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the "Company" or "Rivalry") (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for digital-first players, is pleased to announce that it has closed the third tranche of its non-brokered private placement (the "Private Placement") previously announced on September 29, 2025. The Company issued 29,937,930 units ("Units") at a price of C$0.05 per Unit (the "Offering Price"), for gross proceeds of C$1,496,896.50. Each Unit consists of one (1) subordinate voting share in the capital of the Company (each, a "SV Share") and one (1) SV Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable into one (1) SV Share (each, a "Warrant Share") at a price of C$0.10 per Warrant Share until October 8, 2027. The SV Shares, Warrants and Warrant Shares are subject to a four-month statutory hold period, in accordance with applicable securities legislation. The Company intends to use the net proceeds from the Private Placement for corporate development and general working capital purposes. The Company may complete a final tranche of the Private Placement on or prior to November 15, 2025.

The Company is also pleased to announce the closing of its previously announced debt restructuring pursuant to a debt settlement agreement dated September 26, 2025 (the "Debt Settlement Agreement") with the Company's senior lender (the "Senior Lender"). Pursuant to the Debt Settlement Agreement, the Company and the Senior Lender restructured the Company's indebtedness with the Senior Lender, comprised of (i) the senior secured convertible debenture issued by the Company on November 14, 2023, in the principal amount of C$14,000,000 (the "Secured Debenture"), and (ii) certain unsecured promissory notes in the aggregate principal amount of US$3,070,000 maturing September 30, 2025 (collectively, the "Indebtedness").

Pursuant to the Debt Settlement Agreement, the Company and the Senior Lender satisfied C$12,526,384.88 of Indebtedness owing by the Company to the Senior Lender through the issuance of 250,527,697 units (the "Debt Settlement Units"), at the Offering Price (the "Debt Settlement"). Each Debt Settlement Unit consists of one (1) SV Share and one (1) SV Share purchase warrant (each, a "Debt Settlement Warrant"). Each Debt Settlement Warrant is exercisable into one (1) SV Share (each, a "DS Warrant Share") at a price of C$0.10 per DS Warrant Share until October 24, 2027. C$8,480,000 principal amount of Indebtedness now remains outstanding under the Secured Debenture, which was amended to provide that: (i) the Secured Debenture is convertible into SV Shares at a conversion price of $0.10 per SV Share; (ii) the maturity date of the Secured Debenture is November 14, 2028; and (iii) no interest is payable under the Secured Debenture until December 31, 2026 (collectively, the "Debenture Amendments" and, together with the Debt Settlement, the "Debt Restructuring"). The securities issued in connection with the Debt Restructuring are subject to a four-month statutory hold period, in accordance with applicable securities legislation.

As a result of the Debt Restructuring, the Senior Lender became a “control person” of the Company within the meaning of applicable securities laws. In accordance with the policies of the TSXV, the Company obtained shareholder approval in connection with the creation of a new control person by written consent executed by holders of more than 50% of the voting rights attached to the issued and outstanding voting shares of the Company.

“The completion of this transaction closes an important chapter for Rivalry. Over the past year we rebuilt the business, reduced operating costs, improved unit economics, and secured new capital while restructuring our debt. With a stronger balance sheet and long-term aligned partner, Rivalry is positioned to continue driving focused execution and growth,” said Steven Salz, Co-Founder and CEO of Rivalry.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any applicable state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration requirements is available.

About Rivalry

Rivalry Corp. wholly owns and operates Rivalry Limited, a leading sport betting and media company offering fully regulated online wagering on esports, traditional sports, and casino for the digital generation. Based in Toronto, Rivalry operates a global team in more than 20 countries and growing. Rivalry Limited has held an Isle of Man license since 2018, considered one of the premier online gambling jurisdictions, as well as an internet gaming registration in Ontario, and is currently in the process of obtaining additional country licenses. With world class creative execution and brand positioning in online culture, a native crypto token, and demonstrated market leadership among digital-first users, Rivalry is shaping the future of online gambling for a generation born on the internet.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Company Contact:
Steven Salz, Co-founder & CEO
[email protected]

Investor Contact:
[email protected]      

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws (“forward-looking statements”). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “achieve”, “could”, “believe”, “plan”, “intend”, “objective”, “continuous”, “ongoing”, “estimate”, “outlook”, “expect”, “project” and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions “may” or “will” occur. These statements are only predictions.

Forward-looking statements are based on the opinions and estimates of management of the Company at the date the statements are made based on information then available to the Company. Various factors and assumptions are applied in drawing conclusions or making the forecasts or projections set out in forward-looking statements. Forward-looking statements are subject to and involve a number of known and unknown, variables, risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company’s actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such factors, among other things, include regulatory or political change such as changes in applicable laws and regulations; the ability to obtain and maintain required licenses; the esports and sports betting industry being a heavily regulated industry; the complex and evolving regulatory environment for the online gaming and online gambling industry; the success of esports and other betting products are not guaranteed; changes in public perception of the esports and online gambling industry; failure to retain or add customers; the Company having a limited operating history; negative cash flow from operations and the Company’s ability to operate as a going concern; operational risks; cybersecurity risks; reliance on management; reliance on third parties and third-party networks; exchange rate risks; risks related to cryptocurrency transactions; risk of intellectual property infringement or invalid claims; the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and general economic, market and business conditions. For additional risks, please see the Company’s management’s discussion and analysis for the year ended December 31, 2024 under the heading “Risk Factors”, and other disclosure documents available on the Company’s SEDAR+ profile at www.sedarplus.ca.

No assurance can be given that the expectations reflected in forward-looking statements will prove to be correct. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Source: Rivalry Corp.
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) stocknewsapi
RARE
October 24, 2025 16:30 ET

 | Source:

Ultragenyx Pharmaceutical Inc.

NOVATO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 20,317 restricted stock units of the company’s common stock to 17 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of October 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).

The restricted stock units vest over four years, with 25% of the underlying shares vesting on each anniversary of the grant date, subject to the employee being continuously employed by the company as of such vesting dates.

About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.

Contact Ultragenyx
Investors & Media
Joshua Higa
(415) 475-6370
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
PINTEC Announces Changes in the Board of Directors stocknewsapi
PT
, /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its directors, Mr. Chao Chen and Mr. Tixin Li, resigned from their respective roles on the board of directors of the Company (the "Board"). Their resignations did not result from any disagreement with the Company.

To fill these vacancies, the Board has appointed Mr. Xin Yang and Mr. Hao Liu as directors of the Board. 

Mr. Yang has been serving as the Company's chief financial officer since December 29, 2023. Mr. Yang has 20 years of experience in accounting and financial management. Prior to joining the Company, Mr. Yang served as chief financial officer at Shenzhen Longchengfa Technology Co., Ltd. from October 2021 to December 2023. Mr. Yang received his bachelor's degree from Central University of Finance and Economics in 2004.

Mr. Liu has been serving as an independent director of 3 E NETWORK TECHNOLOGY GROUP LIMITED (NASDAQ: MASK) since December 2024. Prior to that, Mr. Liu held roles of co-founder and chief executive officer at Jeethen Capital from January 2020 to December 2024, overseeing the firm's strategic direction and daily operations. From March to August 2021, Mr. Liu served as CEO and director at Mercurity Fintech Holding Inc. (NASDAQ: MFH), where he led the company's successful business transformation and service optimization. From October 2017 to February 2019, Mr. Liu served as chief technology officer at Huasheng Securities, where he enhanced the firm's fintech infrastructure and digital services through his technical leadership. Mr. Liu also leverages his deep technical expertise and financial industry insight as an angel investor supporting multiple innovative fintech startups. Mr. Liu earned a Bachelor's Degree in Software Engineering from Nanjing University of Science and Technology in 2008.

"We extend our sincere gratitude to Mr. Chen and Mr. Li for their valuable contributions and dedicated service to PINTEC. Their leadership and insights have played an important role in shaping the Company's strategic direction." said Mr. Jun Dong, chairman of the Board. "At the same time, we are pleased to welcome Mr. Yang and Mr. Liu to the Board. We are confident that their appointments will further strengthen the Board and support PINTEC's continued growth and innovation."

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Among other things, the quotations from management in this announcement, as well as Pintec's strategic and operational plans, contain forward-looking statements. Pintec may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, the Company's limited operating history, regulatory uncertainties relating to the markets and industries where the Company operates, and the need to further diversify its financial partners, the Company's reliance on a limited number of business partners, the impact of current or future PRC laws or regulations on wealth management financial products, and the Company's ability to meet the standards necessary to maintain the listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About Pintec

PINTEC is a Nasdaq-listed technology company dedicated to delivering innovative financial and digital solutions to micro, small, and medium enterprises worldwide. Through its open platform, PINTEC connects business partners and financial institutions, enabling them to provide efficient, technology-driven services to end users across international markets. By empowering partners with embedded financing capabilities and advanced digital tools, PINTEC helps businesses expand their offerings and supports financial institutions in reaching new customer segments in the digital economy. PINTEC continues to deliver exceptional digitization services, diversified financial products, and best-in-class solutions powered by cutting-edge technology, strengthening partnerships and meeting global client needs. For more information, please visit ir.Pintec.com.

SOURCE Pintec Technology Holdings Limited

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
CCL Industries Announces Bolt-on Acquisition for Avery stocknewsapi
CCDBF CCLLF
TORONTO, ONTARIO / ACCESS Newswire / October 24, 2025 / CCL Industries Inc., (TSX:CCL.A, CCL.B) a world leader in specialty label, security and packaging solutions for global corporations, government institutions, small businesses and consumers, announced today that it has acquired IDESCO Holding Corporation and IDSecurityonline.com, LLC, privately owned providers of secure badging and identification solutions based in Manhattan, New York. Sales for calendar year 2024 were approximately $21.5 million with an estimated 14.2% adjusted EBIT margin.
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
PLAYSTUDIOS to Release Third Quarter 2025 Results on November 3rd stocknewsapi
MYPS
-

LAS VEGAS--(BUSINESS WIRE)--PLAYSTUDIOS, Inc. (Nasdaq: MYPS) (“PLAYSTUDIOS” or the “Company”), the creator of the playAWARDS loyalty platform and an award-winning developer and publisher of free-to-play mobile and social games, today announced that it will release its third quarter 2025 results after the close of the market on Monday, November 3, 2025.

The Company will host a conference call and audio webcast on Monday, November 3, 2025 at 5:00 pm Eastern Time to discuss the results. To listen to the audio webcast and live Q&A, please visit the PLAYSTUDIOS investor relations website at ir.playstudios.com. Interested parties may also access the call by dialing (866) 405-1203 or (201) 689-8432. An audio replay will be available on the PLAYSTUDIOS investor relations website shortly after the call.

About PLAYSTUDIOS

PLAYSTUDIOS, Inc. (Nasdaq: MYPS), creator of the groundbreaking playAWARDS loyalty platform, is a publisher and developer of award-winning mobile games, including the iconic Tetris® mobile app, Solitaire, Spider Solitaire, and Sudoku, and its casino-style games such as myVEGAS Slots, myVEGAS Blackjack, myVEGAS Bingo, POP! Slots, MGM Slots Live, and myKONAMI Slots. The playAWARDS loyalty platform enables players to earn real-world rewards from a global collection of hospitality, entertainment, and leisure brands. playAWARDS partners include MGM Resorts International, Wolfgang Puck, Norwegian Cruise Line, Resorts World, IHG Hotels & Resorts, Bowlero, Gray Line Tours, and Hippodrome Casino among others. Founded by a team of veteran gaming, hospitality, and technology entrepreneurs, PLAYSTUDIOS apps combine the best elements of popular casual games with compelling real-world benefits. To learn more about PLAYSTUDIOS, visit www.playstudios.com.

More News From PLAYSTUDIOS, Inc.

Back to Newsroom
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
Overlooked Stock: LITE's Rally Boosted by AAPL & A.I. Infrastructure stocknewsapi
AAPL LITE
Lumentum Holdings (LITE) is up more than 110% so far in 2025. Part of its rally is attributed to Lumentum's Apple (AAPL) connection.
2025-10-24 21:02 6mo ago
2025-10-24 16:30 6mo ago
HVAC Stock Rockets 86% With Earnings Ahead stocknewsapi
FIX
Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveProfile SettingsCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Profile Settings

Recently Searched

AMSC3.19%

AMSC3.19%

Agnico-Eagle Among 4 Hot Gold Miners Earnings A Spot On Best Stock Lists. Find Winners On IBD 50, Big Cap 20 And More

AMZN1.44%

AMZN1.44%

Indexes Rise As More Mag Seven Earnings Loom; Tesla Reverses Higher

CRWD4.37%

CRWD4.37%

Dow Jones Futures: Intel, AI Play Jump Late After Tesla Makes Bullish Move

Comfort Systems (FIX) surged off its 50-day moving average on Friday. Shares of the building air conditioning and heating products maker broke through a three-weeks-tight pattern with a 19% gain Friday, well above a buy point of 861.77. The HVAC stock now sits at an all-time high. With Friday's big move, shares have rallied 130% year to date. The company…
2025-10-24 21:02 6mo ago
2025-10-24 16:34 6mo ago
Rise Gold Closes US$7,000,000 Financing stocknewsapi
RYES
October 24, 2025 4:34 PM EDT | Source: Rise Gold Corp.
Grass Valley, California--(Newsfile Corp. - October 24, 2025) - Rise Gold Corp. (CSE: RISE) (OTCQB: RYES) (the "Company" or "Rise") is pleased to announce that it has closed the non-brokered private placement of units ("Units") announced in its October 17, 2025 news release (the "Financing").

The Company raised a total of US$7,000,000 through the sale of 28,000,000 units (each a "Unit") at a price of US$0.25 per Unit (~CDN$0.35 per Unit). Each Unit consists of one share of common stock (a "Share") and one common share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase an additional Share of the Company at an exercise price of US$0.45 (~CDN$0.63) until October 24, 2028.

The Company has paid finder's fees in accordance with CSE policies of US$1,500 and issued a total of 6,000 finder's warrants, with each finder's warrant entitling the holder to acquire one Share at a price of US$0.45 until October 24, 2028.

Rise would like to thank each of the subscribers who participated in this private placement to support the Company's efforts to unlock the value of the historic Idaho-Maryland-Brunswick Mine (the "IM Mine").

The IM Mine produced 2.4 million ounces at a mill grade of 17 grams per tonne from the 1860s to 1956. In 2023, Nevada County (the "County") published an Environmental Impact Report comprised of more than 40,000 pages that concluded that all of the environmental impacts of Rise's proposed project could be mitigated to a "less than significant" effect with three minor exceptions: visual changes to Rise's surface property, temporary noise related to construction, and some traffic effects at a single intersection.

County Supervisors then denied Rise's permit application on spurious grounds. As previously disclosed by a news release (https://www.risegoldcorp.com/news_items) issued on September 16, 2025, the Company expects that in the first quarter of 2026 the Superior Court will render its decision on Rise's writ of mandamus filed against the County with regards to the Company's vested right to operate the mine. Should the Court reject Rise's writ, the County will have taken Rise's mineral estate and will owe just compensation-the fair market value of the property taken-under the Fifth Amendment of the U.S. Constitution. Based on comparable mines and historic yields at the I-M Mine, management believes the fair market value of Rise's mineral estate is at least $400 million.

The Company would like to thank especially Abdiel Capital Advisors, which invested US$3.6 million in this Financing and now owns 12% of the Company on an undiluted basis, as well as Equinox Partners, which invested US$1.4 million in this Financing to retain its 19.8% undiluted interest in the Company. Myrmikan Gold Fund also participated, investing US$250,000, which puts its undiluted ownership stake in the Company at 12.2%.

Joe Mullin, President and CEO, stated: "We are pleased to have Abdiel as a shareholder and also that Equinox retained its 19.8% interest in the Company. Rise is now fully financed to expand its litigation efforts to allow the I-M Mine to move forward towards development."

Certain directors and officers of Rise Gold, directly, through entities controlled by them, or through entities for which they exercise control or direction over investment decisions, purchased an aggregate of 1,080,000 Units for gross proceeds of US$270,000. The participation of these directors and officers in the Financing constitutes a "related party transaction" under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Rise Gold is relying on exemptions from the formal valuation requirements of section 5.4 of MI 61-101 and minority shareholder approval requirements of section 5.6 of MI 61-101. As the fair market value of the related parties' participation is not more than 25% of Rise Gold's market capitalization, the related party transaction is exempt from the formal valuation requirements pursuant to subsection 5.5(a) of MI 61-101 and from the minority approval requirements pursuant to subsection 5.7(1)(a) of MI 61-101. A material change report, as contemplated by the related party transaction requirements under MI 61-101, was not filed more than 21 days prior to closing as the extent of related party participation in the Financing was not known until shortly prior to the closing.

All securities issued pursuant to the Financing are subject to statutory hold periods in accordance with applicable United States and Canadian securities laws. Under Canadian securities laws the securities are subject to a hold period expiring on February 25, 2026. Rise Gold will use the proceeds from the Financing for general working capital, legal expenses, and technical work.

The securities offered have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold absent registration or compliance with an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.

About Rise Gold Corp.

Rise Gold is an exploration-stage mining company incorporated in Nevada, USA. The Company's principal asset is the historic past-producing Idaho-Maryland Gold Mine located in Nevada County, California, USA.

On behalf of the Board of Directors:

Joseph Mullin
President and CEO
Rise Gold Corp.

The CSE has not reviewed, approved or disapproved the contents of this news release.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words or statements that certain events or conditions "may" or "will" occur. This information and these statements are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, the anticipated use of the proceeds raised under the Financing, the potential reopening of the IM Mine, the anticipated timing of the Superior Court decision on Rise's writ of mandamus, and the expected fair market value of Rise's mineral estate.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks, uncertainties and assumptions related to certain factors including, without limitation, the risk that the Company will not be able to utilize the proceeds of the Financing as anticipated, the risk that the Superior Court will not render its decision on the timing anticipated, obtaining all necessary approvals, meeting expenditure and financing requirements, compliance with environmental regulations, title matters, operating hazards, metal prices, political and economic factors, competitive factors, general economic conditions, relationships with vendors and strategic partners, governmental regulation and supervision, seasonality, technological change, industry practices, and one-time events that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements and information contained in this release. Rise undertakes no obligation to update forward-looking statements or information except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271905
2025-10-24 21:02 6mo ago
2025-10-24 16:35 6mo ago
Manhattan Bridge Capital, Inc. Reports Third Quarter 2025 Results stocknewsapi
LOAN
GREAT NECK, N.Y., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its net income for the three months ended September 30, 2025 was approximately $1,202,000, or $0.11 per basic and diluted share (based on approximately 11.4 million weighted-average outstanding common shares), as compared to approximately $1,399,000, or $0.12 per basic and diluted share (based on approximately 11.4 million weighted-average outstanding common shares), for the three months ended September 30, 2024, a decrease of $197,000, or 14.1%. This decrease is primarily attributable to a decrease in revenue, partially offset by a decrease in interest expense.

Total revenues for the three months ended September 30, 2025 were approximately $2,036,000 compared to approximately $2,313,000 for the three months ended September 30, 2024, a decrease of $277,000 or 12.0%. The decrease in revenue was primarily attributable to lower interest income, resulting from a reduction in loans receivable, period-over-period, and reduced origination fees, which were impacted by a slowdown in new loan originations. For the three months ended September 30, 2025 and 2024, approximately $1,770,000 and $1,953,000, respectively, of the Company’s revenues were attributable to interest income on secured commercial loans that the Company offered to real estate investors, and approximately $265,000 and $360,000, respectively, of its revenues were attributable to origination fees on such loans. The loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers.

Net income for the nine months ended September 30, 2025 was approximately $3,988,000, or $0.35 per basic and diluted share (based on approximately 11.4 million weighted-average outstanding common shares), as compared to approximately $4,285,000, or $0.37 per basic and diluted share (based on approximately 11.4 million weighted-average outstanding common shares), for the nine months ended September 30, 2024, a decrease of $297,000, or 6.9%. This decrease is primarily attributable to a decrease in interest income, partially offset by a decrease in interest expense.

Total revenues for the nine months ended September 30, 2025 were approximately $6,665,000 compared to approximately $7,330,000 for the nine months ended September 30, 2024, a decrease of $665,000, or 9.1%. The decrease in revenue was primarily attributable to lower interest income, resulting from a reduction in loans receivable, period-over-period, and reduced origination fees, which were impacted by a slowdown in new loan originations. For the nine months ended September 30, 2025 and 2024, revenues of approximately $5,504,000 and $6,128,000, respectively, were attributable to interest income on secured commercial loans that the Company offered to real estate investors, and approximately $1,161,000 and $1,201,000, respectively, of the Company’s revenues were attributable to origination fees on such loans. The loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers.

As of September 30, 2025, total stockholders' equity was approximately $43,317,000.

Assaf Ran, Chairman of the Board and Chief Executive Officer of the Company, stated, “The good news is that paid off loans during the third quarter exceeded our average, reflecting the strength and high quality of our loans even in rough times. However, the slow real estate markets in the geographic areas in which we operate causes longer time to redevelopment. Thus the decline in revenue and income. We continue to work tirelessly to deploy the available funds into safe and secure loans.”

About Manhattan Bridge Capital, Inc.

Manhattan Bridge Capital, Inc. offers short-term secured, non–banking loans (sometimes referred to as “hard money” loans) to real estate investors to fund their acquisition, renovation, rehabilitation or improvement of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. We operate the website: https://www.manhattanbridgecapital.com.

Forward Looking Statements

This press release and the statements of the Company’s representatives related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” are intended to identify forward-looking statements. For example, when the Company discusses the slow real estate markets, as well the deployment of available funds into safe and secure loans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors, including but not limited to the following: (i) our loan origination activities, revenues and profits are limited by available funds; (ii) we operate in a highly competitive market and competition may limit our ability to originate loans with favorable interest rates; (iii) our Chief Executive Officer is critical to our business and our future success may depend on our ability to retain him; (iv) if we overestimate the yields on our loans or incorrectly value the collateral securing the loan, we may experience losses; (v) we may be subject to “lender liability” claims; (vi) our due diligence may not uncover all of a borrower’s liabilities or other risks to its business; (vii) borrower concentration could lead to significant losses; (viii) we may choose to make distributions in our own stock, in which case you may be required to pay income taxes in excess of the cash dividends you receive; (ix) an increase in interest rates may impact our profitability; (x) we may be unsuccessful in our efforts to extend or replace our existing credit line; and (xi) we may be unsuccessful in our efforts to redeem our 6% senior secured notes, due April 22, 2026. The risk factors contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission identify important factors that could cause such differences. These forward-looking statements speak only as of the date of this press release, and we caution potential investors not to place undue reliance on such statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

 MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS AssetsSeptember 30, 2025
(unaudited)
 December 31, 2024
(audited)
Loans receivable, net of deferred origination and other fees$57,961,155  $65,405,731 Interest and other fees receivable on loans 1,578,806   1,521,033 Cash
 186,435   178,012 Cash – restricted 13,847   23,750 Other assets 128,431   62,080 Right-of-use asset – operating lease, net 114,429   154,039 Deferred financing costs, net 5,775   16,171 Total assets$59,988,878  $67,360,816  Liabilities and Stockholders’ Equity   Liabilities:   Line of credit$9,049,624  $16,427,874 Senior secured notes (net of deferred financing costs of $40,672 and $96,985, respectively) 5,959,328   5,903,015 Accounts payable and accrued expenses 171,558   232,236 Operating lease liability 126,051   167,119 Loan holdback 50,000   50,000 Dividends payable 1,315,445   1,315,445 Total liabilities 16,672,006   24,095,689     Commitments and contingencies       Stockholders’ equity:   Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding ---   --- Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 outstanding 11,757   11,757 Additional paid-in capital 45,571,739   45,561,941 Less: Treasury shares, at cost – 318,407 shares (1,070,406)  (1,070,406)Accumulated deficit (1,196,218)  (1,238,165)Total stockholders’ equity 43,316,872   43,265,127         Total liabilities and stockholders’ equity$59,988,878  $67,360,816   MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
  Three Months
Ended September 30,Nine Months
Ended September 30,  2025 2024 2025  2024 Revenue:
Interest income from loans$1,770,377$1,952,957$5,503,694 $6,128,131 Origination fees 265,376 360,376 1,161,008  1,201,494 Total revenue 2,035,753 2,313,333 6,664,702  7,329,625      Operating costs and expenses:    Interest and amortization of deferred financing costs 421,980 537,218 1,379,595  1,831,037 Referral fees 2,575 847 4,242  1,847 General and administrative expenses 413,518 380,482 1,304,873  1,225,041 Total operating costs and expenses 838,073 918,547 2,688,710  3,057,925 Income from operations 1,197,680 1,394,786 3,975,992  4,271,700 Other income 4,500 4,500 13,500  13,500 Income before income tax expense 1,202,180 1,399,286 3,989,492  4,285,200 Income tax expense --- --- (1,210) (650)Net income$1,202,180$1,399,286$3,988,282 $4,284,550      Basic and diluted net income per common share outstanding:    --Basic$0.11$0.12$0.35 $0.37 --Diluted$0.11$0.12$0.35 $0.37      Weighted average number of common shares outstanding:    --Basic 11,438,651 11,438,651 11,438,651  11,438,658 --Diluted 11,438,651 11,438,651 11,438,651  11,438,658   MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(unaudited) FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025 Common SharesAdditional Paid in CapitalTreasury SharesAccumulated DeficitTotals SharesAmount SharesCost  Balance, July 1, 202511,757,058$11,757$45,568,473318,407$(1,070,406)$(1,082,953)$43,426,871 Non-cash compensation   3,266    3,266 Dividends declared and payable      (1,315,445) (1,315,445)Net income                                                   1,202,180  1,202,180 Balance, September 30, 202511,757,058$11,757$45,571,739318,407$(1,070,406)$(1,196,218)$43,316,872  FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2024 Common SharesAdditional Paid in CapitalTreasury SharesAccumulated DeficitTotals SharesAmount SharesCost  Balance, July 1, 202411,757,058$11,757$45,555,408318,407$(1,070,406)$(1,312,947)$43,183,812 Non-cash compensation   3,266    3,266 Dividends declared and payable      (1,315,445) (1,315,445)Net income                                          1,399,286  1,399,286 Balance, September 30, 202411,757,058$11,757$45,558,674318,407$(1,070,406)$(1,229,106)$43,270,919  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 Common SharesAdditional Paid in CapitalTreasury SharesAccumulated DeficitTotals SharesAmount SharesCost  Balance, January 1, 202511,757,058$11,757$45,561,941318,407$(1,070,406)$(1,238,165)$43,265,127 Non-cash compensation   9,798    9,798 Dividends paid      (2,630,890) (2,630,890)Dividends declared and payable      (1,315,445) (1,315,445)Net income                                          3,988,282  3,988,282 Balance, September 30, 202511,757,058$11,757$45,571,739318,407$(1,070,406)$(1,196,218)$43,316,872  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024 Common SharesAdditional Paid in CapitalTreasury SharesAccumulated DeficitTotals SharesAmount SharesCost  Balance, January 1, 202411,757,058$11,757$45,548,876316,407$(1,060,606)$(1,567,321)$42,932,706 Purchase of treasury shares   2,000 (9,800)  (9,800)Non-cash compensation   9,798    9,798 Dividends paid      (2,630,890) (2,630,890)Dividends declared and payable      (1,315,445) (1,315,445)Net income                                          4,284,550  4,284,550 Balance, September 30, 202411,757,058$11,757$45,558,674318,407$(1,070,406)$(1,229,106)$43,270,919   MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
   Nine Months
Ended September 30,   2025   2024 Cash flows from operating activities:    Net income $3,988,282  $4,284,550 Adjustments to reconcile net income to net cash provided by operating activities -    Amortization of deferred financing costs  66,710   66,427 Adjustment to right-of-use asset - operating lease and liability  (1,459)  121 Depreciation  4,007   3,480 Non-cash compensation expense  9,798   9,798 Changes in operating assets and liabilities:    Interest and other fees receivable on loans  (70,895)  (484,660)Other assets  (69,940)  (35,005)Accounts payable and accrued expenses  (60,678)  (83,505)Deferred origination and other fees  (59,801)  (100,207)Net cash provided by operating activities  3,806,024   3,660,999      Cash flows from investing activities:    Issuance of short-term loans  (27,957,494)  (29,019,000)Collections received from loans  35,474,993   33,749,887 Purchase of fixed assets  (418)  (4,018)Net cash provided by investing activities  7,517,081   4,726,869      Cash flows from financing activities:    Repayment of line of credit  (40,751,845)  (37,297,880)Proceeds from line of credit  33,373,595   31,315,810 Dividends paid  (3,946,335)  (3,917,963)Purchase of treasury shares  ---   (9,800)Deferred financing costs incurred  ---   (2,167)Net cash used in financing activities  (11,324,585)  (9,912,000)     Net decrease in cash  (1,480)  (1,524,132)Cash and restricted cash, beginning of period(1)  201,762   1,691,995 Cash and restricted cash, end of period(2) $200,282  $167,863      Supplemental Disclosure of Cash Flow Information:    Cash paid during the period for taxes $1,210  $650 Cash paid during the period for interest $1,346,361  $1,816,980 Cash paid during the period for operating leases $47,973  $47,779      Supplemental Schedule of Noncash Financing Activities:    Dividend declared and payable $1,315,445 $1,315,445 Loan holdback relating to mortgage receivable $--- $50,000      Supplemental Schedule of Noncash Operating and Investing Activities:    Reduction in interest receivable in connection with the increase in loans receivable $13,122 $343,922  (1) At December 31, 2024 and 2023, cash and restricted cash included $23,750 and $1,587,773, respectively, of restricted cash.
(2) At September 30, 2025, cash and restricted cash included $13,847 of restricted cash.
2025-10-24 21:02 6mo ago
2025-10-24 16:35 6mo ago
Gold (XAU/USD) Price Forecast: Three-Day Consolidation – Breakout Decides Next Move stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
Support Levels
The 20-day average, now at $4,056, anchors support, with the channel line adding weight. The 10-day average at $4,185, once dynamic support, now acts as resistance, as seen Wednesday. Holding $4,044 keeps the bullish structure intact, but a break below risks a deeper correction.

Trade Setup
A rally above Wednesday’s $4,161 high would trigger a bullish reversal from the three-day range, targeting higher prices within the $4,080-$4,375 zone. The 61.8% Fibonacci retracement at $4,237 and 78.6% at $4,300 are key levels, with $4,381 record high in sight if bulls dominate. A counter-trend bounce off support post-Tuesday’s selloff aligns with the channel’s validation.

Risks Ahead
Muted volatility could form a bear flag if the three-day range expands. A drop below $4,044 signals weakness, breaking the 20-day average, while sub-$4,003 confirms a stronger bearish move. With only one corrective leg so far, a bounce to a lower high could be followed by a second leg down.

Outlook
The $4,056 close decides—above $4,161 fuels a $4,237 push, below $4,044 eyes $4,003. The hammer and channel support favor bulls, but $4,185 resistance may cap rallies. Watch for breakout strength or consolidation — $4,381 remains possible if momentum holds, but a bear flag warns of lower tests of support.

For a look at all of today’s economic events, check out our economic calendar.
2025-10-24 21:02 6mo ago
2025-10-24 16:44 6mo ago
Biotech Stocks Returned To Health And Offered Multiple Entries stocknewsapi
XBI
After peaking in February 2021, biotech stocks as a group didn't participate once the market turned around after 2022. This summer seems to have changed that.

Biotech stocks are not easy to handle individually. The development stage cohort is filled with stocks that have no earnings and often no revenue, except for inconsistent milestone payments.

That just happens to be the majority of members in the nearly 800 stock Medical-Biomed/Biotech group. But the SPDR S&P Biotech ETF (XBI) can get you the exposure without the worry of a clinical trial or dangerous side effect of a single drug blasting your portfolio into oblivion.

Conquering The 200-day Line Starts The Journey
XBI struggled under its 200-day line for most of the year. Even when the April 22 follow-through day triggered, XBI still had 17% to go to retake the long-term trendline.

Our strategy was patience. After rising well off its bottom, XBI joined SwingTrader on Aug. 13 as it retook its 200-day line (1). As we typically do, we started trimming the position into strength in what turned out to be a downside reversal day (2). We exited the remainder the next day as we fell back below our entry price (3). But the trade still finished with over a 0.5% gain. How? The earlier sell locked in profits and helped keep the trade green instead of taking a loss.

After a couple of weeks, we gave the biotech ETF another shot as it broke above resistance (4). This time, we trimmed the position back a little early as we failed to make initial progress (5). With so many positions acting well, it was hard to stick with a position that wasn't. However, we adjusted the next day and added the trimmed position back immediately as strength returned (6). Unfortunately, XBI went sideways again and we ended up exiting with a small loss on the trade (7). If positions don't perform, the exits usually come quickly to keep moving where the relative strength is.

Sometimes it's not as easy to buy back positions. When the biotech stocks started moving again (8), we were already on margin. Unfortunately, this was when XBI started to really run.

Looking For New Chances At Biotech Stocks
Just because you miss a run doesn't mean you should swear off any future trades. An upside reversal at the 10-day line gave us another chance at the biotech stocks (9). This time, instead of taking profits into strength we leaned in bringing XBI to an oversize position the next day (10).

It was one of the few areas that were working after the Oct. 10 sell-off but we didn't want to push our luck. We started trimming on a downside reversal (11) and exited after XBI took out the lows of the prior few days the next week (12). Now with the strength to end the week on Friday, it's worth looking at for another try.

More details on past trades are accessible to subscribers and trialists to SwingTrader. Free trials are available. Follow Nielsen on X, formerly known as Twitter, at @IBD_JNielsen.

YOU MAY ALSO LIKE:

Why This IBD Tool Simplifies The Search For Top Stocks

Learn How To Time The Market With IBD's ETF Strategy

Getting The Proper Mindset Puts You On The Right Side Of Any Market

Looking For The Next Stock Market Winner? Start With These 3 Steps
2025-10-24 21:02 6mo ago
2025-10-24 16:45 6mo ago
First Capital, Inc. Reports Record Quarterly Earnings stocknewsapi
FCAP
CORYDON, Ind., Oct. 24, 2025 (GLOBE NEWSWIRE) -- First Capital, Inc. (the “Company”) (NASDAQ: FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $4.5 million, or $1.34 per diluted share, for the quarter ended September 30, 2025, compared to net income of $2.9 million, or $0.87 per diluted share, for the quarter ended September 30, 2024.

Results of Operations for the Three Months Ended September 30, 2025 and 2024

Net interest income after provision for credit losses increased $2.1 million for the quarter ended September 30, 2025 compared to the same period in 2024. Interest income increased $1.4 million when comparing the two periods due to an increase in the average tax-equivalent yield(1) on interest-earning assets from 4.59% for the quarter ended September 30, 2024 to 4.94% for the same period in 2025, in addition to an increase in the average balance of interest-earning assets from $1.17 billion for the quarter ended September 30, 2024 to $1.20 billion for the same period in 2025. Interest expense decreased $397,000 when comparing the two periods. The average cost of interest-bearing liabilities decreased from 1.87% for the quarter ended September 30, 2024 to 1.66% for the same period in 2025, while the average balance of interest-bearing liabilities increased from $875.8 million for the quarter ended September 30, 2024 to $891.3 million for the same period in 2025. As a result of the changes in interest-earning assets and interest-bearing liabilities, the tax-equivalent net interest margin(1) increased from 3.19% for the quarter ended September 30, 2024 to 3.71% for the same period in 2025. Refer to the accompanying average balance sheet for more information regarding changes in the composition of the Company’s balance sheet and resulting yields and costs from the quarter ended September 30, 2024 to the quarter ended September 30, 2025.

Based on management’s analysis of the Allowance for Credit Losses (“ACL”) on loans and unfunded loan commitments, the provision for credit losses decreased from $463,000 for the quarter ended September 30, 2024 to $150,000 for the quarter ended September 30, 2025. The Bank recognized net charge-offs of $17,000 and $64,000 for the quarters ended September 30, 2025 and 2024, respectively.

Noninterest income increased $506,000 for the quarter ended September 30, 2025 as compared to the quarter ended September 30, 2024 primarily due to the Company recognizing a $150,000 gain on equity securities for the quarter ended September 30, 2025 compared to a $196,000 loss on equity securities for the quarter ended September 30, 2024. In addition, the Company recognized a $119,000 increase in gains on sale of loans as well as an increase of $47,000 in ATM and debit card fee income when comparing the two periods. These increases were partially offset by the Company recognizing a net $39,000 loss on sale of available for sale securities during the quarter ended September 30, 2025. The Company did not sell any securities during the quarter ended September 30, 2024.

Noninterest expenses increased $540,000 for the quarter ended September 30, 2025 as compared to the same period in 2024. This was primarily due to increases in occupancy and equipment and compensation and benefits expenses of $331,000 and $202,000, respectively. The increase in occupancy and equipment expenses is primarily due to costs for the demolition and subsequent rebuilding of one of the Bank’s Bullitt County branches in addition to a loss recognized for the remaining net book value of assets associated with the branch. The increase in compensation and benefits is due to increases in salary and wages associated with annual cost of living and performance related adjustments.

Income tax expense increased $530,000 for the quarter ended September 30, 2025 as compared to the same period in 2024 resulting in an effective tax rate of 19.2% for the quarter ended September 30, 2025, compared to 15.6% for the same period in 2024. The increase in the Bank’s effective tax rate for the quarter reflects a higher proportion of net income being subject to taxation compared to the same period last year.

Results of Operations for the Nine Months Ended September 30, 2025 and 2024

For the nine months ended September 30, 2025, the Company reported net income of $11.5 million, or $3.43 per diluted share, compared to net income of $8.7 million, or $2.59 per diluted share, for the same period in 2024.

Net interest income after provision for credit losses increased $4.9 million for the nine months ended September 30, 2025 compared to the same period in 2024. Interest income increased $4.8 million when comparing the two periods due to an increase in the average tax-equivalent yield(1) on interest-earning assets from 4.44% for the nine months ended September 30, 2024 to 4.80% for the same period in 2025, in addition to an increase in the average balance of interest-earning assets from $1.14 billion for the nine months ended September 30, 2024 to $1.19 billion for the same period in 2025. Interest expense increased $198,000 as the average cost of interest-bearing liabilities decreased from 1.72% for the nine months ended September 30, 2024 to 1.67% for the same period in 2025 while the average balance of interest-bearing liabilities increased from $846.8 million for the nine months ended September 30, 2024 to $886.0 million for the same period in 2025. As a result of the changes in interest-earning assets and interest-bearing liabilities, the tax-equivalent net interest margin(1) increased from 3.16% for the nine months ended September 30, 2024 to 3.55% for the same period in 2025. Refer to the accompanying average balance sheet for more information regarding changes in the composition of the Company’s balance sheet and resulting yields and costs from the nine months ended September 30, 2024 to the nine months ended September 30, 2025.

Based on management’s analysis of the ACL on loans and unfunded loan commitments, the provision for credit losses decreased from $1.1 million for the nine months ended September 30, 2024 to $794,000 for the nine months ended September 30, 2025. The decrease was due to a decrease in non-performing loans and management’s assessment of the macroeconomic environment. The Bank recognized net charge-offs of $214,000 and $149,000 for the nine months ended September 30, 2025 and 2024, respectively.

Noninterest income increased $450,000 for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. The increase is primarily due to the Company recognizing a $127,000 gain on equity securities for the nine months ended September 30, 2025 compared to a loss of $270,000 for the same period in 2024. In addition, the Company also recognized a $90,000 increase in gains on sale of loans and a $39,000 increase in service charges on deposits when comparing the two periods. These were partially offset by the Company recognizing a net $94,000 loss on sale of available for sale securities for the nine months ended September 30, 2025 compared to a net gain of $32,000 on sale of available for sale securities for the same period in 2024.

Noninterest expenses increased $1.5 million for the nine months ended September 30, 2025 as compared to the same period in 2024. This was primarily due to increases in compensation and benefits and occupancy and equipment expenses of $769,000 and $560,000, respectively, when comparing the two periods. The increase in compensation and benefits is due to increases in salary and wages associated with annual cost of living and performance related adjustments as well as increases in the cost of Company-provided health insurance benefits. The increase in occupancy and equipment expenses is primarily due to costs associated with snow removal across the Company’s branch network in the first quarter of 2025, as well as losses on the disposal of premises and equipment associated with two of the Bank’s branches, the upgrade of the Company’s call center system, and the demolition of one of the Bank’s branches.

Income tax expense increased $1.1 million for the nine months ended September 30, 2025 as compared to the same period in 2024 resulting in an effective tax rate of 18.4% for the nine months ended September 30, 2025, compared to 15.0% for the same period in 2024. The increase in the Bank’s effective tax rate for the nine months ended September 30, 2025 reflects a higher proportion of net income being subject to taxation compared to the same period last year.

Comparison of Financial Condition at September 30, 2025 and December 31, 2024

Total assets were $1.24 billion at September 30, 2025 compared to $1.19 billion at December 31, 2024. Securities available for sale, net loans receivable and cash and cash equivalents increased $32.4 million, $11.1 million, and $6.3 million, respectively, from December 31, 2024 to September 30, 2025. Deposits increased $28.3 million from $1.07 billion at December 31, 2024 to $1.09 billion at September 30, 2025. Nonperforming assets (consisting of nonaccrual loans, accruing loans 90 days or more past due, and foreclosed real estate) decreased from $4.4 million at December 31, 2024 to $3.9 million at September 30, 2025.

The Bank currently has 17 offices in the Indiana communities of Corydon, Edwardsville, Greenville, Floyds Knobs, Palmyra, New Albany, New Salisbury, Jeffersonville, Salem, Lanesville and Charlestown and the Kentucky communities of Shepherdsville, Mt. Washington and Lebanon Junction.

Access to First Harrison Bank accounts, including online banking and electronic bill payments, is available through the Bank’s website at www.firstharrison.com. For more information and financial data about the Company, please visit Investor Relations at the Bank’s aforementioned website. The Bank can also be followed on Facebook.

(1) Reconciliations of the non–U.S. Generally Accepted Accounting Principles (“GAAP”) measures are set forth at the end of this press release.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of the words “anticipate,” “believe,” “expect,” “intend,” “could” and “should,” and other words of similar meaning. Forward-looking statements are not historical facts nor guarantees of future performance; rather, they are statements based on the Company’s current beliefs, assumptions, and expectations regarding its business strategies and their intended results and its future performance.

Numerous risks and uncertainties could cause or contribute to the Company’s actual results, performance and achievements to be materially different from those expressed or implied by these forward-looking statements. Factors that may cause or contribute to these differences include, without limitation, general economic conditions, including changes in market interest rates and changes in monetary and fiscal policies of the federal government; competition; the ability of the Company to execute its business plan; legislative and regulatory changes; the quality and composition of the loan and investment portfolios; loan demand; deposit flows; changes in accounting principles and guidelines; and other factors disclosed periodically in the Company’s filings with the Securities and Exchange Commission.

Because of the risks and uncertainties inherent in forward-looking statements, readers are cautioned not to place undue reliance on them, whether included in this press release, the Company’s reports, or made elsewhere from time to time by the Company or on its behalf. These forward-looking statements are made only as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements after the date of this press release.

Contact:
Joshua P. Stevens
Chief Financial Officer
812-738-1570

 FIRST CAPITAL, INC. AND SUBSIDIARIES
Consolidated Financial Highlights (Unaudited)   Three Months Ended Nine Months Ended  September 30, September 30,OPERATING DATA 2025
 2024
 2025
 2024
(Dollars in thousands, except per share data)                         Total interest income $14,658  $13,224  $42,044  $37,279 Total interest expense  3,702   4,099   11,095   10,897 Net interest income  10,956   9,125   30,949   26,382 Provision for credit losses  150   463   794   1,103 Net interest income after provision for credit losses  10,806   8,662   30,155   25,279              Total non-interest income  2,306   1,800   6,172   5,722 Total non-interest expense  7,564   7,024   22,239   20,781 Income before income taxes  5,548   3,438   14,088   10,220 Income tax expense  1,067   537   2,591   1,532 Net income  4,481   2,901   11,497   8,688 Less net income attributable to the noncontrolling interest  3   3   9   10 Net income attributable to First Capital, Inc. $4,478  $2,898  $11,488  $8,678              Net income per share attributable to            First Capital, Inc. common shareholders:            Basic $1.34  $0.87  $3.43  $2.59              Diluted $1.34  $0.87  $3.43  $2.59              Weighted average common shares outstanding:            Basic  3,348,618   3,347,236   3,347,380   3,345,863              Diluted  3,350,008   3,347,236   3,349,321   3,345,863              OTHER FINANCIAL DATA                         Cash dividends per share $0.31  $0.29  $0.89  $0.83 Return on average assets (annualized)  1.45%  0.97%  1.26%  0.99%Return on average equity (annualized)  14.29%  10.48%  12.70%  10.84%Net interest margin  3.64%  3.12%  3.48%  3.09%Net interest margin (tax-equivalent basis) (1)  3.71%  3.19%  3.55%  3.16%Interest rate spread  3.21%  2.66%  3.06%  2.65%Interest rate spread (tax-equivalent basis) (1)  3.28%  2.72%  3.13%  2.72%Net overhead expense as a percentage of average assets (annualized)  2.44%  2.35%  2.44%  2.38%          September 30, December 31,BALANCE SHEET INFORMATION 2025
 2024
       Cash and cash equivalents $112,177  $105,917 Interest-bearing time deposits  2,205   2,695 Investment securities  428,627   396,243 Gross loans  652,193   640,480 Allowance for credit losses  9,861   9,281 Earning assets  1,167,634   1,119,944 Total assets  1,235,477   1,187,523 Deposits  1,094,733   1,066,439 Stockholders' equity, net of noncontrolling interest  132,441   114,599 Allowance for credit losses as a percentage of gross loans  1.51%  1.45%Non-performing assets:      Nonaccrual loans  3,866   4,382 Accruing loans past due 90 days  —   — Foreclosed real estate  —   — Regulatory capital ratios (Bank only):      Community Bank Leverage Ratio (2)  10.82%  10.57% ________________
(1)  See reconciliation of GAAP and non-GAAP financial measures for additional information relating to the calculation of this item.
(2)  Effective March 31, 2020, the Bank opted in to the Community Bank Leverage Ratio (CBLR) framework. As such, the other regulatory ratios are no longer provided.

  FIRST CAPITAL, INC. AND SUBSIDIARIES
Consolidated Average Balance Sheets (Unaudited)   For the Three Months ended September 30,  2025
 2024
        Average       Average  Average   Yield/ Average   Yield/  Balance Interest Cost Balance Interest Cost(Dollars in thousands)                Interest earning assets:                Loans (1) (2):                Taxable $640,178 $10,323  6.45% $627,244 $9,633  6.14%Tax-exempt (3)  10,328  109  4.22%  10,405  105  4.04%Total loans  650,506  10,432  6.41%  637,649  9,738  6.11%                 Investment securities:                Taxable (4)  318,628  2,282  2.86%  328,441  1,757  2.14%Tax-exempt (3)  118,840  866  2.91%  118,360  795  2.69%Total investment securities  437,468  3,148  2.88%  446,801  2,552  2.28%                 Interest bearing deposits with banks (5)  115,623  1,283  4.44%  83,761  1,123  5.36%                 Total interest earning assets  1,203,597  14,863  4.94%  1,168,211  13,413  4.59%                 Non-interest earning assets  33,930       28,584     Total assets $1,237,527      $1,196,795                      Interest bearing liabilities:                Interest-bearing demand deposits $437,040 $1,318  1.21% $452,173 $1,777  1.57%Savings accounts  227,997  154  0.27%  226,683  205  0.36%Time deposits  226,309  2,230  3.94%  163,271  1,706  4.18%Total deposits  891,346  3,702  1.66%  842,127  3,688  1.75%                 FHLB Advances  —  —  —   —  —  — Bank Term Funding Program Borrowings  —  —  —   33,625  411  4.89%Total interest bearing liabilities  891,346  3,702  1.66%  875,752  4,099  1.87%                 Non-interest bearing liabilities                Non-interest bearing deposits  211,573       202,404     Other liabilities  9,236       8,004     Total liabilities  1,112,155       1,086,160     Stockholders' equity (6)  125,372       110,635     Total liabilities and stockholders' equity $1,237,527      $1,196,795                      Net interest income (tax-equivalent basis)    $11,161       $9,314   Less: tax equivalent adjustment     (205)       (189)  Net interest income    $10,956       $9,125                    Interest rate spread       3.21%       2.66%Interest rate spread (tax-equivalent basis) (7)       3.28%       2.72%Net interest margin       3.64%       3.12%Net interest margin (tax-equivalent basis) (7)       3.71%       3.19%Ratio of average interest earning assets to average interest bearing liabilities       135.03%       133.40% ________________
(1)  Interest income on loans includes fee income of $202,000 and $159,000 for the three months ended September 30, 2025 and 2024, respectively.
(2)  Average loan balances include loans held for sale and nonperforming loans.
(3)  Tax-exempt income has been adjusted to a tax-equivalent basis using the federal marginal tax rate of 21%.
(4)  Includes taxable debt and equity securities and FHLB Stock.
(5)  Includes interest-bearing deposits with banks and interest-bearing time deposits.
(6)  Stockholders' equity attributable to First Capital, Inc.
(7)  Reconciliations of the non–U.S. GAAP measures are set forth at the end of this press release.

  FIRST CAPITAL, INC. AND SUBSIDIARIES
Consolidated Average Balance Sheets (Unaudited)   For the Nine Months ended September 30,   2025
 2024
        Average       Average  Average    Yield/ Average    Yield/  Balance Interest Cost Balance Interest Cost(Dollars in thousands)                Interest earning assets:                Loans (1) (2):                Taxable $638,950 $30,172  6.30% $623,208 $28,226  6.04%Tax-exempt (3)  10,632  337  4.23%  9,290  254  3.65%Total loans  649,582  30,509  6.26%  632,498  28,480  6.00%                 Investment securities:                Taxable (4)  312,409  6,146  2.62%  339,525  5,179  2.03%Tax-exempt (3)  118,714  2,529  2.84%  122,115  2,491  2.72%Total investment securities  431,123  8,675  2.68%  461,640  7,670  2.22%                 Interest bearing deposits with banks (5)  104,396  3,462  4.42%  42,962  1,706  5.29%                 Total interest earning assets  1,185,101  42,646  4.80%  1,137,100  37,856  4.44%                 Non-interest earning assets  32,472       27,721     Total assets $1,217,573      $1,164,821                      Interest bearing liabilities:                Interest-bearing demand deposits $438,971 $4,061  1.23% $432,126 $4,551  1.40%Savings accounts  227,231  482  0.28%  232,382  650  0.37%Time deposits  219,751  6,552  3.98%  146,939  4,396  3.99%Total deposits  885,953  11,095  1.67%  811,447  9,597  1.58%                 FHLB Advances  —  —  —   2,319  99  5.69%Bank Term Funding Program Borrowings  —  —  —   33,055  1,201  4.84%Total interest bearing liabilities  885,953  11,095  1.67%  846,821  10,897  1.72%                 Non-interest bearing liabilities                Non-interest bearing deposits  202,719       204,267     Other liabilities  8,287       6,959     Total liabilities  1,096,959       1,058,047     Stockholders' equity (6)  120,614       106,774     Total liabilities and stockholders' equity $1,217,573      $1,164,821                      Net interest income (tax-equivalent basis)    $31,551       $26,959   Less: tax equivalent adjustment     (602)       (577)  Net interest income    $30,949       $26,382                    Interest rate spread       3.06%       2.65%Interest rate spread (tax-equivalent basis) (7)       3.13%       2.72%Net interest margin       3.48%       3.09%Net interest margin (tax-equivalent basis) (7)       3.55%       3.16%Ratio of average interest earning assets to average interest bearing liabilities       133.77%       134.28% ________________
(1)  Interest income on loans includes fee income of $599,000 and $517,000 for the nine months ended September 30, 2025 and 2024, respectively.
(2)  Average loan balances include loans held for sale and nonperforming loans.
(3)  Tax-exempt income has been adjusted to a tax-equivalent basis using the federal marginal tax rate of 21%.
(4)  Includes taxable debt and equity securities and FHLB Stock.
(5)  Includes interest-bearing deposits with banks and interest-bearing time deposits.
(6)  Stockholders' equity attributable to First Capital, Inc.
(7)  Reconciliations of the non–U.S. GAAP measures are set forth at the end of this press release.

RECONCILIATION OF GAAP AND NON-GAAP FINANCIAL MEASURES (UNAUDITED):

This presentation contains financial information determined by methods other than in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management uses these “non-GAAP” measures in its analysis of the Company's performance. Management believes that these non-GAAP financial measures allow for better comparability with prior periods, as well as with peers in the industry who provide a similar presentation, and provide a further understanding of the Company's ongoing operations. These disclosures should not be viewed as a substitute for operating results determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other companies. The following table summarizes the non-GAAP financial measures derived from amounts reported in the Company's consolidated financial statements and reconciles those non-GAAP financial measures with the comparable GAAP financial measures.

               Three Months Ended Nine Months Ended  September 30, September 30,  2025
 2024
 2025
 2024
(Dollars in thousands)            Net interest income (A) $10,956  $9,125  $30,949  $26,382 Add: Tax-equivalent adjustment  205   189   602   577 Tax-equivalent net interest income (B)  11,161   9,314   31,551   26,959 Average interest earning assets (C)  1,203,597   1,168,211   1,185,101   1,137,100 Net interest margin (A)/(C)  3.64%  3.12%  3.48%  3.09%Net interest margin (tax-equivalent basis) (B)/(C)  3.71%  3.19%  3.55%  3.16%             Total interest income (D) $14,658  $13,224  $42,044  $37,279 Add: Tax-equivalent adjustment  205   189   602   577 Total interest income tax-equivalent basis (E)  14,863   13,413   42,646   37,856 Average interest earning assets (F)  1,203,597   1,168,211   1,185,101   1,137,100 Average yield on interest earning assets (D)/(F); (G)  4.87%  4.53%  4.73%  4.37%Average yield on interest earning assets tax-equivalent (E)/(F); (H)  4.94%  4.59%  4.80%  4.44%Average cost of interest bearing liabilities (I)  1.66%  1.87%  1.67%  1.72%Interest rate spread (G)-(I)  3.21%  2.66%  3.06%  2.65%Interest rate spread tax-equivalent (H)-(I)  3.28%  2.72%  3.13%  2.72%
2025-10-24 21:02 6mo ago
2025-10-24 16:46 6mo ago
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights stocknewsapi
AGL
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=46039 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On August 4, 2025, agilon health issued a press release entitled “agilon health Reports Second Quarter 2025 Results.” Commenting on the results, agilon health’s Executive Chair stated that “as we progressed through this transition year, it’s become clear that the industry headwinds are more acute than previously expected[.]” Further, the release announced that the company was “suspending its previously issued full-year 2025 financial guidance and related assumptions.”

On this news, agilon health’s stock fell 51.5% on August 5, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com
2025-10-24 21:02 6mo ago
2025-10-24 16:46 6mo ago
Undercovered Dozen: Antero Resources, Red Cat Holdings, CoreWeave And More stocknewsapi
AR CRWV RCAT
SummaryThe Undercovered Dozen series spotlights 12 lesser-known stocks highlighted in recent Seeking Alpha articles.This week's edition covers articles published between October 17 and October 23, offering fresh investment ideas.The series aims to inspire discussion and help investors discover overlooked opportunities in the market.Readers are encouraged to share their thoughts and suggest additional undercovered stocks worth following. chrisdorney/iStock via Getty Images

The Undercovered Dozen is a weekly Seeking Alpha editor-curated series highlighting 12 articles on lesser-covered stocks from the previous seven days. We hope this provides ideas and inspires discussion among the community.

Today, we're looking at

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given that any particular security, portfolio, transaction or investment strategy is suitable for any specific person. The author is not advising you personally concerning the nature, potential, value or suitability of any particular security or other matter. You alone are solely responsible for determining whether any investment, security or strategy, or any product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. The author is an employee of Seeking Alpha. Any views or opinions expressed herein may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Recommended For You
2025-10-24 21:02 6mo ago
2025-10-24 16:50 6mo ago
Enzon and Viskase Announce Amendment to Merger Agreement stocknewsapi
ENZN
Enzon and Viskase stockholders will respectively own 45% and 55% of the combined company

October 24, 2025 16:50 ET

 | Source:

Enzon Pharmaceuticals, Inc

CRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (“Viskase”) today announced that they have entered into an amendment (the “Amendment”) to the previously disclosed Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Viskase will merge with and into a wholly owned subsidiary of Enzon in an all-stock transaction (the “Merger”). The Amendment was entered into to reflect recent developments in the operations of Viskase during the past several months and its expected operations in the near term.

Pursuant to the terms of the Amendment, the parties agreed, among other things, to:

an adjustment to the exchange ratio as calculated under the Merger Agreement for the exchange of each share of common stock, par value $0.01 per share, of Viskase, issued and outstanding immediately prior to the Merger into shares of the common stock, par value $0.01 per share, of Enzon (the “Enzon Common Stock”), such that current Viskase stockholders will own 55% of the combined company following the Merger;an adjustment to the exchange ratio for the exchange of each share of Enzon’s Series C Non-Convertible Redeemable Preferred Stock, par value $0.01 per share (the “Series C Preferred Stock”), for shares of Enzon Common Stock to be based upon the 20-day volume weighted average price of Enzon Common Stock prior to execution of the Amendment (the “20-Day VWAP”);a reduction in the minimum amount of cash that Enzon is required to have at the closing of the Merger; Enzon effecting a 1 for 100 reverse stock split with respect to with respect to all shares of Enzon Common Stock prior to the effective time of the Merger; andan extension to the date on which either party may terminate the Merger Agreement if the Merger has not yet occurred from 11:59 p.m., Eastern Time, on December 31, 2025, to 11:59 p.m., Eastern Time, on March 31, 2026.
In connection with the execution and delivery of the Amendment, Icahn Enterprises Holdings L.P. (“IEH”) and certain of its affiliates entered into an amendment (“Support Agreement Amendment”) to the Support Agreement that was previously entered into between IEH, Enzon and Viskase in connection with the execution of the Merger Agreement (the “Support Agreement”). Pursuant to the terms of the Support Agreement (as amended by the Support Agreement Amendment), IEH agreed to, among other things, (i) deliver or cause the delivery of written consents with respect to all of the issued and outstanding shares of Enzon Common Stock held by IEH and its affiliates approving the Merger and the amendment to Enzon’s certificate of incorporation, and (ii) exchange all of the shares of Series C Preferred Stock held by IEH and its affiliates for Enzon Common Stock prior to the consummation of the Merger, based on the full liquidation preference of such shares of Series C Preferred Stock and the 20-Day VWAP.

Enzon believes that the Merger as revised pursuant to the terms of the Amendment will result in Enzon’s net operating losses and other tax benefits to be maintained and available for use by the combined company following the Merger.

The Amendment was recommended by a special committee of the independent directors of Enzon and was recommended by a special committee of the independent directors of Viskase and, acting upon such recommendations, was, respectively approved by the Boards of Directors of each of Enzon and Viskase.

About Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc., together with its subsidiary, is positioned as a public company acquisition vehicle, that has sought to become an acquisition platform.

About Viskase Companies, Inc.

Viskase Companies, Inc., together with its subsidiaries, is a producer of non-edible cellulosic, fibrous and plastic casings used to prepare and package processed meat products, and provides value-added support services relating to these products, for some of the largest global consumer product companies. Viskase operates nine manufacturing facilities in North America, Europe, South America, and Asia, and, as a result, is able to sell its products in nearly one hundred countries throughout the world.

No Offer or Solicitation

This communication is not intended to be, and shall not constitute, an offer to sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Important Information About the Merger and Where to Find It

In connection with the proposed transactions between Enzon and Viskase, Enzon intends to file a registration statement on Form S-4 with the Securities and Exchange Commission (the “SEC”) that will contain a consent solicitation statement and prospectus (the “Registration Statement”). The Registration Statement will include financial information regarding the combined company. This communication is not a substitute for the Registration Statement or any other documents that Enzon may file with the SEC or that Enzon or Viskase may send to their respective stockholders in connection with the transactions contemplated by the Merger Agreement, as amended. BEFORE MAKING ANY VOTING DECISION, ENZON AND VISKASE URGE INVESTORS AND STOCKHOLDERS TO READ THESE MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ENZON, THE COMBINED COMPANY, THE MERGER AGREEMENT, AS AMENDED, AND THE TRANSACTIONS CONTEMPLATED THEREBY, INCLUDING THE MERGER, AND RELATED MATTERS.

You may obtain free copies of the Registration Statement and all other documents filed or that will be filed with the SEC regarding the proposed transaction at the website maintained by the SEC at www.sec.gov. Once filed, the Registration Statement will be available free of charge on Enzon’s website at https://www.enzon.com. Investors and stockholders are urged to read the Registration Statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.

Participants in the Solicitation

Each of Enzon and Viskase and each of their respective directors and executive officers and certain of their other members of management and employees may be deemed to be participants in the solicitation of consents or proxies in connection with the Merger Agreement, as amended, and the transactions contemplated thereby, including the Merger. Information about Enzon’s directors and executive officers is included in Enzon’s Amendment No. 1 to the Annual Report on Form 10-K/A for the year ended December 31, 2024, filed with the SEC on April 28, 2025, and Enzon’s definitive proxy statement for its 2024 Annual Meeting of Stockholders, filed with the SEC on August 8, 2024. Additional information regarding these persons and their interests in the transactions contemplated by the Merger Agreement, as amended, as well as information regarding Viskase’s directors and executive officers, will be included in the Registration Statement relating to the Merger Agreement, as amended, and the transactions contemplated thereby, including the Merger, when it is filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Cautionary Statements Regarding Forward-Looking Statements

Certain statements contained in this filing may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the proposed transaction involving Enzon and Viskase, the ability to consummate the proposed transaction, and the ability to quote the common stock of the combined company on the “OTCQB” tier of the OTC market of the OTC Markets Group, Inc. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to obtain the necessary approvals for the proposed transaction; (ii) uncertainties as to the timing of the consummation of the proposed transaction, including timing for satisfaction of the closing conditions, and the ability of each of Enzon and Viskase to consummate the proposed transaction; (iii) the ability of Viskase to timely deliver the financial statements required by the Merger Agreement, as amended; (iv) the possibility that other anticipated benefits of the proposed transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the combined company’s operations, and the anticipated tax treatment of the combination; (v) potential litigation relating to the proposed transaction that could be instituted against Enzon, Viskase or their respective officers or directors; (vi) possible disruptions from the proposed transaction that could harm Enzon’s or Viskase’s respective businesses; (vii) the ability of Viskase to retain, attract and hire key personnel; (viii) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (ix) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Enzon’s or Viskase’s financial performance; (x) certain restrictions during the pendency of the proposed transaction that may impact Enzon’s or Viskase’s ability to pursue certain business opportunities or strategic transactions; (xi) the exchange ratio and relative ownership levels as of the closing of the transactions contemplated by the Merger Agreement, as amended; (xii) estimates regarding future revenue, expenses, and capital requirements following the closing of the transactions contemplated by the Merger Agreement, as amended; (xiii) legislative, regulatory and economic developments; (xiv) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, trade wars, or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors; and (xv) such other risks and uncertainties, including those that are set forth in the Registration Statement under the heading “Risk Factors”, in Enzon’s periodic public filings with the SEC, and in Viskase’s annual and quarterly reports posted to Viskase’s website. Enzon and Viskase can give no assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Enzon, nor Viskase undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Richard L. Feinstein, CEO and CFO
Email: [email protected]
2025-10-24 21:02 6mo ago
2025-10-24 16:50 6mo ago
Apple Q4 Earnings Preview: $4 Trillion Market Capitalization Ahead stocknewsapi
AAPL
Analyst’s Disclosure:I/we have a beneficial long position in the shares of AAPL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-24 21:02 6mo ago
2025-10-24 16:51 6mo ago
Meta: An AI Infrastructure Play In Disguise stocknewsapi
META
SummaryMeta Platforms is transforming into a vertically integrated AI infrastructure leader, controlling every layer from data centers to proprietary AI models.Meta’s massive CAPEX in AI infrastructure is building long-term assets, driving future operating leverage, margin expansion, and new profitable revenue streams.Despite industry-leading margins and its strategic positioning, Meta trades at a discount to tech peers, making the current price an appealing buying opportunity.I initiate coverage on the stock with a Strong Buy rating, citing its unique AI value chain integration and attractive valuation amid the ongoing AI super cycle. Galeanu Mihai/iStock via Getty Images

Introduction Meta Platforms (NASDAQ:META) stock has had an incredible run over the last three years. When CEO Mark Zuckerberg announced in early 2023 that the company would start its now-famous 'Year

Analyst’s Disclosure:I/we have a beneficial long position in the shares of META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You
2025-10-24 21:02 6mo ago
2025-10-24 16:55 6mo ago
Usha Resources and Totec Resources Enter Definitive Agreement for Qualifying Transaction stocknewsapi
USHAF
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / Totec Resources Ltd. ("Totec" or the "Company") (TSXV:TOTC.P), a capital pool company, and Usha Resources Ltd.
2025-10-24 21:02 6mo ago
2025-10-24 16:55 6mo ago
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs stocknewsapi
ELAN
EUA to Treat Dogs for NWS Issued Prior to Fly Being Detected in the U.S.; Action Prepares Veterinarians and Pet Owners with Treatment Options

First FDA emergency use authorization (EUA) ever granted for NWS in dogs
Action reinforces agency's commitment to providing treatment options for NWS in advance of the fly being detected in the U.S.
Published literature showed Credelio may be effective in treating NWS in dogsi
Preventing open wounds through effective flea and tick control is critical in protecting pets from NWS

, /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Credelio™ (lotilaner) to treat New World screwworm (NWS) infestations in dogs. This is the first EUA ever granted by the Agency for NWS in dogs. Confirmed cases of NWS have been detected less than 70 miles south of the U.S.-Mexico border.ii This Emergency Use Authorization allows veterinarians and pet owners to have a ready-now treatment option if the fly enters the U.S.

"We appreciate the FDA's review of the scientific data demonstrating that Credelio may be an effective treatment against New World screwworm in dogs," said Dr. Ellen de Brabander, Executive Vice President of Innovation and Regulatory Affairs at Elanco. "This first ever Emergency Use Authorization for NWS in dogs gives veterinarians and pet owners peace of mind, knowing there's an authorized treatment option available as soon as they may need it."

The Emergency Use Authorization was based on a study evaluating the efficacy of Credelio against NWS. In the peer-reviewed study, published in Parasites & Vectors, oral administration of Credelio at the minimum recommended dosage demonstrated 100% efficacy against C. hominivorax larvae (NWS) within 24 hours of treatment in naturally infested dogs.i

There are limitations of the data supporting the benefits of Credelio for the treatment of infestations caused by NWS larvae. The study was conducted in a limited population of eleven naturally infested dogs in Brazil, and the inferential value to the United States population is unknown. The primary mechanism of action against C. hominivorax appears to be live larval expulsion. Additionally, the use of mechanical removal coupled with the lack of a control group confound the ability to define a pure treatment effect.

Effective Parasite Protection is Key

Even before NWS enters our country, veterinarians and pet owners can take precautions to prevent wounds that can create ideal conditions for NWS infection. NWS infestations begin when a female NWS fly lays eggs on open wounds or other parts of the body in live, warm-blooded animals. According to the Centers for Disease Control, wounds as small as a tick bite may attract a female fly to feed and lay her eggs. One female can lay 200 – 300 eggs at a time and may lay up to 1,000 eggs during her 10- to 30-day lifespan.iii Unlike most fly species whose larvae may feed on dead and decaying tissue, NWS larvae burrow into the flesh of living animals, causing severe tissue damage and even death if left untreated.

The U.S. Animal Plant Health and Inspection Service (APHIS) recommends that one way to prevent NWS infestations is to protect pets and livestock from other wound-causing parasites such as flies and ticks.iv

"Any break in the skin – from a scratch to a surgical incision – can become an entry point for NWS, due to its aggressive and invasive nature," said Dr. Casey Locklear, Texas-based veterinarian and parasiticide lead at Elanco. "Preventing or rapidly treating existing wounds is critical to protecting pets from NWS. One way to limit self-inflicted scratching includes using year-round flea and tick protection, such as Credelio."

Learn more about Credelio here.

To learn more about NWS, the following resources are available:

FDA Information for Veterinarians on New World Screwworm
USDA NWS Alert and Fact Sheet

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.

Emergency Use Authorization for Credelio (lotilaner) for New World screwworm (NWS)

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the approved product Credelio (lotilaner) for the treatment of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies. However, Credelio is not approved for this use.

Credelio is approved for other uses.

For additional information on the EUA, please refer to the Credelio NWS Fact Sheet.

Limitations of Authorized Use

Credelio (lotilaner) is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of Credelio (lotilaner) under section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

CREDELIO INDICATIONS
Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations and treatment and control of tick infestations (lone star tick, American dog tick, black-legged tick, brown dog tick, and longhorned tick) for one month in dogs and puppies 8 weeks and older and 4.4 pounds or greater. Credelio is indicated for the prevention of Lyme disease infections as a direct result of killing black-legged ticks.

CREDELIO IMPORTANT SAFETY INFORMATION
Lotilaner is a member of the isoxazoline class of drugs. This class has been associated with neurologic adverse reactions including tremors, incoordination, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, increased urination, and diarrhea. For complete safety information, please see Credelio product label or ask your veterinarian.

Credelio, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Other company and product names are trademarks of their respective owners. © 2025 Elanco or its affiliates

i d do Vale, T.L., Costa, A.R., Miranda, L.M. et al. Efficacy of lotilaner against myiasis caused by Cochliomyia hominivorax (Diptera: Calliphoridae) in naturally infested dogs. Parasites Vectors 16, 86 (2023). https://doi.org/10.1186/s13071-023-05661-z
ii Mexico Confirms Case of New World Screwworm in Nuevo Leon | Animal and Plant Health Inspection Service
iii About New World Screwworm Myiasis | Myiasis | CDC
iv APHIS, New World Screwworm

Investor Contact: Tiffany Kanaga (765) 740-0314 [email protected]
Media Contact: Season Solorio (765) 316-0233 [email protected]  

SOURCE Elanco Animal Health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-24 21:02 6mo ago
2025-10-24 16:56 6mo ago
Grindr Special Committee Confirms Receipt of Take-Private Proposal from Large Shareholders stocknewsapi
GRND
-

WEST HOLLYWOOD, Calif.--(BUSINESS WIRE)--Grindr Inc. (NYSE: GRND) (“Grindr” or the “Company”), the Global Gayborhood in Your Pocket™, today confirmed that the Special Committee of its Board of Directors (the “Board”) has received a non-binding, unsolicited take-private proposal from large shareholders Ray Zage and James Lu (the “Proposing Shareholders”) to acquire Grindr for $18.00 per share in cash. The Proposing Shareholders, together with their affiliated entities, currently beneficially own more than 60% of the outstanding shares of the Company’s common stock.

As previously announced on October 14, 2025, the Board formed a Special Committee comprised of disinterested and independent directors in response to interest expressed by the Proposing Shareholders in exploring a possible transaction. “The Special Committee, in consultation with its legal and financial advisors, is reviewing the unsolicited take-private proposal and will be evaluating the best path forward for all shareholders,” said Special Committee Chair, Chad Cohen.

There is no assurance that this proposal will result in a transaction or any other strategic outcome. The Company does not intend to comment or update further unless and until further disclosure is determined to be appropriate or necessary. Grindr remains focused on continuing to deliver strong execution and serving its distinctive user base, for whom the Grindr app is of vital importance in their day-to-day lives.

J.P. Morgan Securities LLC is acting as financial advisor to the Special Committee, and Vinson & Elkins LLP is acting as legal counsel to the Special Committee.

More News From Grindr Inc.

Back to Newsroom
2025-10-24 21:02 6mo ago
2025-10-24 16:57 6mo ago
Mohawk Industries, Inc. (MHK) Q3 2025 Earnings Call Transcript stocknewsapi
MHK
Q3: 2025-10-23 Earnings SummaryEPS of $2.67 beats by $0.03

 |

Revenue of

$2.76B

(1.43% Y/Y)

beats by $27.22M

Mohawk Industries, Inc. (NYSE:MHK) Q3 2025 Earnings Call October 24, 2025 11:00 AM EDT

Company Participants

James Brunk - Chief Financial Officer
Jeff Lorberbaum - Chairman & CEO
Paul De Cock - President & COO

Conference Call Participants

John Lovallo - UBS Investment Bank, Research Division
Matthew Bouley - Barclays Bank PLC, Research Division
Collin Verron - Deutsche Bank AG, Research Division
Rafe Jadrosich - BofA Securities, Research Division
Susan Maklari - Goldman Sachs Group, Inc., Research Division
Richard Reid - Wells Fargo Securities, LLC, Research Division
Keith Hughes - Truist Securities, Inc., Research Division
Michael Rehaut - JPMorgan Chase & Co, Research Division
Adam Baumgarten - Vertical Research Partners, LLC
Philip Ng - Jefferies LLC, Research Division
Aatish Shah
Trevor Allinson - Wolfe Research, LLC
Christopher Kalata - RBC Capital Markets, Research Division
Timothy Wojs - Robert W. Baird & Co. Incorporated, Research Division

Presentation

Operator

Good day, everyone, and welcome to the Mohawk Industries Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please also note today's event is being recorded.

At this time, I'd like to turn the floor over to James Brunk, Chief Financial Officer. Please go ahead.

James Brunk
Chief Financial Officer

Thank you, Jamie. Good morning, everyone. Welcome to Mohawk Industries quarterly investor conference call. Joining me on the call are Jeff Lorberbaum, Chairman and Chief Executive Officer; and Paul De Cock, President and Chief Operating Officer. Today, we'll update you on the company's third quarter performance and provide guidance for the fourth quarter of 2025.

I'd like to remind everyone that our press release and statements that we make during this call may include forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, which are subject to various risks and uncertainties, including, but not limited to, those set forth in our press release and our periodic filings with the Securities and Exchange Commission.

Recommended For You
2025-10-24 21:02 6mo ago
2025-10-24 16:57 6mo ago
GrafTech International Ltd. (EAF) Q3 2025 Earnings Call Transcript stocknewsapi
EAF
Q3: 2025-10-24 Earnings SummaryEPS of -$1.03 beats by $0.17

 |

Revenue of

$144.00M

(10.21% Y/Y)

beats by $4.67M

GrafTech International Ltd. (NYSE:EAF) Q3 2025 Earnings Call October 24, 2025 10:00 AM EDT

Company Participants

Michael Dillon - Vice President of Investor Relations & Communications
Timothy Flanagan - CEO, President & Director
Rory O'Donnell - CFO & Senior Vice President

Conference Call Participants

Arun Viswanathan - RBC Capital Markets, Research Division
Bennett Moore - JPMorgan Chase & Co, Research Division
Jay Spencer - Stifel Financial Corp.

Presentation

Operator

Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the GrafTech Third Quarter 2025 Earnings Conference Call and Webcast. [Operator Instructions]

I would now like to turn the conference over to Mike Dillon, Vice President of Investor Relations. You may begin.

Michael Dillon
Vice President of Investor Relations & Communications

Thank you, Desiree. Good morning, and welcome to GrafTech International's Third Quarter 2025 Earnings Call. On with me today are Tim Flanagan, Chief Executive Officer; and Rory O’Donnell, Chief Financial Officer. Tim will begin with opening comments, including an update on the commercial environment. Rory will then provide more details on our quarterly results and other financial matters, and Tim will close with additional comments on our outlook. We will then open the call to questions.

Turning to our next slide. As a reminder, some of the matters discussed on this call may include forward-looking statements regarding, among other things, performance, trends and strategies. These statements are based on current expectations and are subject to risks and uncertainties. Factors that could cause actual results to differ materially from those indicated by forward-looking statements are shown here.

We will also discuss certain non-GAAP financial measures, and these slides include the relevant non-GAAP reconciliations. You can find these slides in the Investor Relations section of our

Recommended For You
2025-10-24 21:02 6mo ago
2025-10-24 16:58 6mo ago
S&P 500 Climbs to New Record on Strong Earnings stocknewsapi
IVV SPLG SPXL SPY SSO UPRO VOO
Inflation data Friday helped stocks end the week on a high note; Ford shares jump 12%.
2025-10-24 21:02 6mo ago
2025-10-24 16:59 6mo ago
Fal.Con Europe Could Be CrowdStrike's Early Earnings Catalyst stocknewsapi
CRWD
CrowdStrike Today

$527.32 +5.34 (+1.02%)

As of 04:00 PM Eastern

52-Week Range$294.68▼

$535.52Price Target$496.47

Most companies' earnings reports are headline events. However, investors in CrowdStrike Holdings Inc. NASDAQ: CRWD may get the main event a few weeks early. CrowdStrike is getting ready to present its Fal.Con Europe event Nov. 4-6, roughly three weeks before CrowdStrike reports earnings.

This is an international version of the Fal.Con Las Vegas, which the company hosted in September. At that event, CrowdStrike debuted its Agentic Security Platform. According to the company, this platform “introduces the industry’s richest AI-ready data layer and expands agentic capabilities across the platform...”

Some features of the Agentic Security Platform include:

Enterprise Graph – the platform’s richest AI-ready data layer, integrating telemetry and intelligence for actionable signals.

Charlotte AI AgentWorks – a no-code platform for helping customers build, deploy, and orchestrate trusted security agents.

Centralized Operating Center of the Agentic Ecosystem to coordinate human and machine defenders securely.

An updated persona-aware user console for natural language queries, dashboards, and role-specific workflows.

The benefit to its customers is that it will unify data, intelligence, agents, and governance to secure and operationalize AI securely, intelligently, and at scale.

Fal.Con Europe Is an Extension, Not an Encore
It could be easy to think of Fal.Con Europe like part of a concert tour: the same or similar stagecraft with maybe a slightly different set list. However, with this event happening about six weeks after the initial event, CrowdStrike will likely have hard data to share about how the Agentic Security Platform has been received.

The event also comes shortly after a high-profile outage at Amazon Web Services (AWS), a reminder that even top cloud providers face reliability risks. For CrowdStrike, it underscores how essential resilient cybersecurity has become in an AI-driven enterprise world.

Innovation Justifies Valuation
CrowdStrike is achieving year-over-year revenue and earnings growth, it’s also continuing to capture market share with its Falcon platform. Both of those are bullish for CRWD stock.

CrowdStrike MarketRank™ Stock AnalysisOverall MarketRank™81st Percentile

Analyst RatingModerate Buy

Upside/Downside5.9% Downside

Short Interest LevelHealthy

Dividend StrengthN/A

Environmental Score-1.11

News Sentiment1.24 Insider TradingSelling Shares

Proj. Earnings Growth29.09%

See Full Analysis

However, if you view the stock as a three-legged stool, the valuation leg is the one that may cause some investors to get wobbly. The company’s current price-to-earnings (P/E), price-to-sales (P/S), and price-to-book (P/B) ratios are all expensive compared to CrowdStrike’s historical averages. It's even trading at a premium to some of the frothiest technology stocks. 

That's why it’s important to remember that CrowdStrike has only been publicly traded since 2019. It’s a young company. While CrowdStrike’s valuation metrics remain elevated compared to historical averages, its sustained earnings growth—analysts forecast 29% EPS growth in the next 12 months—supports a premium multiple.

Investors Should Watch for Evidence of Monetization and Market Adoption
The Fal.Con events illustrate CrowdStrike’s continued commitment to innovation. That kind of innovation is critical to show investors that it’s continuing to offer its customers a value proposition that extends beyond the subscription price.

But that kind of high-minded rhetoric has to show up in the company’s revenue and earnings. These Fal.Con events, first in Las Vegas and soon in Europe, are the ideal venues to share updates with investors before the company’s earnings report in late November.

Hold CRWD Stock Before Earnings But Look to Add on Weakness
CRWD stock closed around $499 on Oct. 22. During the past month, it has tried to break above the $500 mark at different times. Those efforts have met resistance, and the stock is now in a range with a bottom around the $477 mark.

That’s a nice consolidation above the stock’s 50-day simple moving average (SMA). Combined with a neutral RSI, CRWD stock is showing neither overbought nor oversold conditions.

The stock chart and modest volume show that investors are waiting for a catalyst to push the stock to a new all-time high. That pause is natural after the stock’s bullish run, which has been in place since December 2022, nearly three years.

That said, investors should be holding CRWD stock ahead of earnings. If the stock gets dragged down amidst the current market pullback, investors can safely buy on weakness. Conversely, investors should use a breakout above $510 to $515 supported by volume expansion and RSI momentum as a buying signal.

Should You Invest $1,000 in CrowdStrike Right Now?Before you consider CrowdStrike, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CrowdStrike wasn't on the list.

While CrowdStrike currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
2025-10-24 21:02 6mo ago
2025-10-24 17:00 6mo ago
Sparq Announces Termination of Investor Relations Agreement stocknewsapi
SPRQF
October 24, 2025 5:00 PM EDT | Source: SPARQ Systems Inc.
Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - Sparq Systems Inc. (TSXV: SPRQ) (OTCQB: SPRQF) (FSE: M26) ("Sparq" or the "Company") announces that it has terminated its investor relations agreement (the "Agreement") with John Welsh. The Agreement was announced by the Company on June 26, 2025. The Company wishes to thank Mr. Welsh for services rendered to the Company.

ABOUT SPARQ

Sparq designs and manufactures next generation single-phase microinverters for residential and commercial solar electric applications. Sparq has developed a proprietary PV solution called the Quad; the Quad inverter optimizes four PV modules with a single microinverter, simplifying design and installation, and lowering cost for solar power installations when compared to existing market offerings. Sparq's head office is located at 945 Princess Street, Kingston, Ontario, K7L 0E9.

Neither the TSXV nor its regulation services provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271861
2025-10-24 20:02 6mo ago
2025-10-24 15:32 6mo ago
AWS Outage Exposes Cracks in Amazon's Cloud Lead stocknewsapi
AMZN
Amazon invented the cloud business with Amazon Web Services, but its recent massive outage and news that startup Anthropic chose competitor Google for new cloud capacity are raising concerns about AWS's cloud dominance. Bloomberg's Matt Day joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.
2025-10-24 20:02 6mo ago
2025-10-24 15:32 6mo ago
Hensoldt: Don't Miss Europe's Re-Energized Defense Play stocknewsapi
HAGHY HNSDF
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-24 20:02 6mo ago
2025-10-24 15:34 6mo ago
DOW Deadline: DOW Investors Have Opportunity to Lead Dow Inc. Securities Fraud Lawsuit stocknewsapi
DOW
, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dow Inc. (NYSE: DOW) between January 30, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important October 28, 2025 lead plaintiff deadline.

So what: If you purchased Dow securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Dow class action, go to https://rosenlegal.com/submit-form/?case_id=44352 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Dow's ability to mitigate macroeconomic and tariff-related headwinds, as well as to maintain the financial flexibility needed to support its lucrative dividend, was overstated; (2) the true scope and severity of the foregoing headwinds' negative impacts on Dow's business and financial condition was understated, particularly with respect to competitive and pricing pressures, softening global sales and demand for Dow's products, and an oversupply of products in Dow's global markets; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Dow class action, go to https://rosenlegal.com/submit-form/?case_id=44352 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-24 20:02 6mo ago
2025-10-24 15:36 6mo ago
Waste Connections Stock Barely Moves Since Q3 Earnings Beat Estimates stocknewsapi
WCN
Key Takeaways Waste Connections' Q3 earnings and revenues topped estimates, rising 6.7% and 5.1% y/y.Solid Waste Collection revenues grew 6.6% y/y, while E&P Waste Treatment rose 21.6%.Adjusted EBITDA slipped 5.4% to $787.4M, with margins down slightly to 33.7% despite solid sales growth.
Waste Connections, Inc. (WCN - Free Report) reported impressive third-quarter 2025 results, wherein earnings and revenues outpaced the Zacks Consensus Estimates.

The stock price has not witnessed any significant impact of the earnings beat since the company released results on Oct. 21.

Waste Connections’ adjusted earnings (excluding 33 cents from non-recurring items) of $1.44 per share surpassed the Zacks Consensus Estimate by 4.4% and increased 6.7% year over year. Revenues of $2.5 billion beat the consensus estimate marginally and grew 5.1% from the year-ago quarter.

WCN shares have declined 5.4% over the past three months compared with the industry's 4% fall and against the 6.1% rally of the Zacks S&P 500 Composite.

WCN’s Q3 Segmental InformationThe Solid Waste Collection segment’s revenues grew 6.6% year over year to $1.7 billion and met our estimate. The Solid Waste Disposal and Transfer segment’s revenues increased marginally from the year-ago quarter to $456.4 million and beat our projection of $440.6 million.

The Solid Waste Recycling segment’s revenues decreased 16.2% on a year-over-year basis to $56.2 million. The figure missed our estimate of $66.1 million. The Intermodal and Other segment’s revenues declined 10.4% from the year-ago quarter to $42 million, which missed our forecast of $49 million.

The E&P Waste Treatment, Recovery and Disposal segment’s revenues rose 21.6% from the year-ago quarter to $179.1 million, outpacing our estimate of $171.9 million.

Waste Connections’ Operating ResultsAdjusted EBITDA in the reported quarter was $787.4 million, down 5.4% from the year-ago quarter. The adjusted EBITDA margin was 33.7%, which decreased 10 basis points from the year-ago quarter.

Operating income totaled $439.6 million compared with the year-ago quarter’s $475.3 million.

Balance Sheet & Cash FlowWaste Connections exited the third quarter of 2025 with cash and cash equivalents of $117.6 million compared with $110.2 million at the end of the preceding quarter. The long-term debt was $8.6 billion compared with the preceding quarter’s $8.3 billion.

In the reported quarter, WCN generated $677.4 million in cash from operating activities. The adjusted free cash flow was $384.6 million. Capital expenditure totaled $297.2 million. The company paid out $81 million worth of dividends in the quarter.

WCN’s FY25 OutlookFor 2025, the company expected revenues of $9.45 billion, lower than the Zacks Consensus Estimate of $9.46 billion. Adjusted EBITDA is anticipated to be $3.12 billion, which is nearly 33% of the top line.

Waste Connections carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings SnapshotEquifax Inc. (EFX - Free Report) reported impressive third-quarter 2025 results.

EFX’s adjusted earnings were $2.04 per share, outpacing the Zacks Consensus Estimate by 5.7% and increasing 10.3% from the year-ago quarter. Total revenues of $1.5 billion surpassed the consensus estimate by 1.5% and grew 6.9% on a year-over-year basis.

Paychex, Inc. (PAYX - Free Report) posted impressive first-quarter fiscal 2026 results.

PAYX’s fiscal first-quarter earnings of $1.22 per share beat the Zacks Consensus Estimate by a slight margin and increased 5.2% from the year-ago quarter. Total revenues of $1.5 billion surpassed the consensus estimate by a slight margin and gained 16.8% from the year-ago quarter.
2025-10-24 20:02 6mo ago
2025-10-24 15:39 6mo ago
Gold's rally on pause: Analysts see correction as ‘healthy' before next leg higher stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.
2025-10-24 20:02 6mo ago
2025-10-24 15:40 6mo ago
Ontario to pause Reagan tariffs ad after Trump terminated Canada trade talks stocknewsapi
EWC
Ontario Premier Doug Ford said Friday the province will pause airing television ads featuring former President Ronald Reagan criticizing tariffs after World Series games this weekend so that U.S.-Canada “trade talks can resume.” Ford's announcement came a day after President Donald Trump terminated trade negotiations with Canada because of the ad, which Ontario has been airing in U.S. markets.
2025-10-24 20:02 6mo ago
2025-10-24 15:45 6mo ago
American Airlines: Rough 2025 Ending On A High Note stocknewsapi
AAL
Analyst’s Disclosure:I/we have a beneficial long position in the shares of AAL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-24 20:02 6mo ago
2025-10-24 15:46 6mo ago
Commercial National Financial Corporation Reports 3rd Quarter 2025 Results stocknewsapi
CEFC
ITHACA, Mich., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Commercial National Financial Corporation (OTCID: CEFC) reported net income for the third quarter of 2025 of $1,791,000 or $0.45 per share compared to third quarter 2024 net income of $1,408,000 or $0.36 per share. Return on Equity was 13.35% for the third quarter of 2025 compared to 11.32% for the third quarter of 2024.

Net interest income for the third quarter of 2025 increased by $460,000 or 9.8% compared to the respective 2024 period. Interest income decreased by $177,000, mainly due to a decrease in loans. Interest expense decreased by $636,000, mainly due to a decrease in wholesale funding and funding costs. Non-interest income increased by $17,000 or 3.1%. Operating expenses increased by $19,000 or 0.5%.

Total assets were $548 million as of September 30, 2025 compared to $574 million as of September 30, 2024. The decrease in assets was mainly due to the repayment of wholesale funding and trust preferred debt totaling $24 million. While total loans decreased by $30 million or 7.3% due to the high-interest rate environment and early loan payoffs, loan quality remained strong with a non-performing assets ratio of 0.26%. Additionally, CEFC’s wholly owned subsidiary, Commercial Bank, remains significantly above “well capitalized” for regulatory purposes.

Visit www.commercial-bank.com to view the latest news releases and other information about CEFC and Commercial Bank.

Selected Financial Data (unaudited):       Quarter Ended Year to Date Sep 30, 2025 Sep 30, 2024 Sep 30, 2025 Sep 30, 2024Return on Equity 13.35%   11.32%  12.36%  11.09% Return on Assets 1.30%   0.98%  1.16%  0.92% Net Interest Margin 3.97%   3.47%  3.82%  3.37%        Sep 30, 2025 Sep 30, 2024    Non-Performing Assets Ratio 0.26%   0.21%     Tier 1 Leverage Capital Ratio(1) 10.86%   10.17%     Total Risk-Based Capital Ratio(1) 17.75%   16.35%     Book Value Per Share$13.90  $12.80     Market Value Per Share$12.10  $9.03     (1)Ratios are for Commercial Bank        Consolidated Statements of Income (unaudited):       Quarter Ended Year to Date Sep 30, 2025 Sep 30, 2024 Sep 30, 2025 Sep 30, 2024Interest Income$6,567,747  $6,744,483 $19,584,846  $20,069,571 Interest Expense 1,430,850   2,067,285  4,630,286   6,322,485 Net Interest Income 5,136,897   4,677,198  14,954,560   13,747,086 Provision for credit losses (22,241)  229  (56,454)  (38,972)Non-interest income 566,870   549,612  1,579,482   1,700,596 Operating Expenses 3,536,970   3,518,227  10,709,151   10,668,945 Income before taxes 2,189,038   1,708,354  5,881,345   4,817,709 Income tax expense 398,025   300,020  1,053,975   836,080 Net Income$1,791,013  $1,408,334 $4,827,370  $3,981,629         Net Income per share – diluted$0.45  $0.36 $1.22  $1.00 Dividends declared$0.14  $0.14 $0.42  $0.42          Consolidated Balance Sheets (unaudited):     Sep 30, 2025 Sep 30, 2024Assets   Cash and cash equivalents$50,432,608  $55,606,415 Time deposits with other banks 1,494,000   1,992,000 Securities 87,151,048   77,226,328 Loans 377,670,851   407,594,529 Allowance for credit losses (3,413,163)  (3,528,332)Loans, net 374,257,688   404,066,197 Premises and equipment, net 9,732,492   10,092,279 Other assets 24,647,796   25,285,806 Total Assets$547,715,632  $574,269,025     Liabilities   Deposits$481,103,001  $505,613,266 FHLB borrowings 1,000,000   4,000,000 Trust preferred 7,310,000   10,310,000 Other liabilities 3,605,711   3,598,596 Total Liabilities 493,018,712   523,521,862     Equity   Total Equity 54,696,920   50,747,163 Total Liabilities and Equity$547,715,632  $574,269,025      Contact:
Benjamin Z. Ogle
CFO
989-875-5562
2025-10-24 20:02 6mo ago
2025-10-24 15:46 6mo ago
Procter & Gamble Q1 Earnings & Sales Beat on Solid Pricing & Mix stocknewsapi
PG
Key Takeaways Procter & Gamble's Q1 sales rose 3% to $22.4B, beating estimates and improving from last year.Core EPS grew 3% to $1.99, driven by solid pricing gains and a favorable product mix.PG reaffirmed its fiscal 2026 outlook, projecting 1-5% sales growth and steady EPS gains.
The Procter & Gamble Company (PG - Free Report) reported solid first-quarter fiscal 2026 results, with sales and earnings per share (EPS) surpassing the Zacks Consensus Estimate and improving year over year. Results benefited from growth across all segments, led by improved pricing and a favorable mix.

Procter & Gamble’s core EPS of $1.99 per share increased 3% from the year-ago quarter and beat the Zacks Consensus Estimate of $1.90. Currency-neutral core EPS also rose 3% year over year.

The company has reported net sales of $22.4 billion, up 3% year over year. Sales also surpassed the Zacks Consensus Estimate of $22.2 billion. On an organic basis (excluding the impacts of acquisitions, divestitures and foreign exchange), sales rose 2% year over year, driven by an increase of 1% each from pricing and favorable mix, while organic volume had a neutral impact in the reported quarter.

Our model predicted year-over-year organic revenue growth of 3.2% for the first quarter of fiscal 2026, with a 1.4% gain from pricing, a 0.8% rally in the product mix and a 1% rise in the organic volume.

The company’s net sales growth for the fiscal first quarter was led by a year-over-year increase of 1% each in the Baby, Feminine & Family Care and Fabric & Home Care, 5% in Grooming, 2% in Health Care and 6% in Beauty segments. Organic sales rose 6% for the Beauty, 3% for Grooming and 1% for Health Care segments. Meanwhile, organic sales were flat for the Baby, Feminine & Family Care and Fabric & Home Care segments.

Shares of PG rose 2.5% in the pre-market session following the strong first-quarter fiscal 2026 results and a decent outlook for fiscal 2026. This Zacks Rank #4 (Sell) company’s stock has lost 3.8% in the past three months compared with the industry’s 6.2% decline.

Image Source: Zacks Investment Research

Procter & Gamble's Q1 MarginsThe core gross margin declined 50 basis points (bps) year over year to 51.5%, while the reported gross margin fell 70 bps. Currency rates aided the gross margin by 0.2%. The currency-neutral core gross margin contracted 30 bps to 51.7%. Gains from gross productivity savings of 140 bps, pricing benefits of 50 bps and 20 bps from rounding and other items were more than offset by 100 bps of adverse product mix, 70 bps of product reinvestments and a 70-bps increase in costs from tariffs and commodities.

Core selling, general and administrative expenses (SG&A), as a percentage of sales, declined 40 bps from the year-ago quarter to 24.9%. The currency-neutral core SG&A rate contracted 70 bps to 24.6%. This decline was backed by 90 bps of productivity savings, 40 bps of net sales growth leverage and 10 bps of rounding and other items. These were partly offset by 70 bps of reinvestment costs.

The core operating margin was flat with the prior year at 26.7%. On a currency-neutral basis, the operating margin increased year over year by 40 bps to 27.1%, mainly aided by the positive currency effect. The operating margin included gross productivity savings of 230 bps.

We expected the core gross profit margin to decline 50 bps year over year in the fiscal first quarter to 51.5%. The core SG&A expense rate was anticipated to increase 20 bps, whereas our core operating margin projection suggested a decline of 80 bps to 25.9%.

Peek Into PG's FinancialsProcter & Gamble ended first-quarter fiscal 2026 with cash and cash equivalents of $11.2 billion, long-term debt of $24.3 billion, and total shareholders’ equity of $53.6 billion.

In the first-quarter fiscal 2026, the company generated an operating cash flow of $5.4 billion. The adjusted free cash flow was $4.9 billion for the three months ended Sept. 30, 2025, with an adjusted free cash flow productivity of 102%.

Procter & Gamble returned $3.8 billion of value to its shareholders in the fiscal first quarter, including $2.55 billion in dividend payouts and $1.25 billion in share buybacks.

PG's Fiscal 2026 GuidanceFor fiscal 2026, Procter & Gamble anticipates delivering another strong year of organic sales growth, core EPS growth and sturdy adjusted free cash flow productivity. Hence, the company reiterated its guidance for fiscal 2026.

The company expects year-over-year all-in sales growth of 1-5% for fiscal 2026, while organic sales are expected to be flat to up 4%. Its all-in sales are expected to include a 1% benefit from currency rates, as well as from acquisitions and divestitures.

PG envisions net EPS growth of 3-9% in fiscal 2026 compared with the fiscal 2025 GAAP EPS of $6.51. The company expects core EPS of $6.83-$7.09, suggesting flat to 4% year-over-year growth from the fiscal 2025 core EPS of $6.83. The core EPS, at a mid-point of $6.96, implies 2% year-over-year growth. PG estimates fiscal 2026 core effective tax rate of 20-21%.

The company predicts a commodity cost headwind of $100 million after tax for fiscal 2026. It also expects higher costs from tariffs of $400-million, after-tax. It anticipates an after-tax headwind of about $250 million, primarily due to modestly higher net interest expenses and an increased core effective tax rate compared to the previous year. However, this is expected to be partially offset by a favorable foreign exchange tailwind of $300 million after tax. In total, these factors are projected to represent a net headwind of roughly 19 cents per share for fiscal 2026.

Procter & Gamble expects capital expenditure to be 4-5% of net sales in fiscal 2026. Adjusted free cash flow productivity is estimated to be 85-90%. The company intends to pay out dividends worth $10 billion and repurchase shares worth $5 billion in fiscal 2026.

Here’s How Better-Ranked Stocks FaredNewell Brands Inc. (NWL - Free Report) is a global manufacturer and marketer of consumer and commercial products. The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Newell Brands delivered a trailing four-quarter earnings surprise of 25%, on average. The Zacks Consensus Estimate for NWL’s current financial-year sales indicates a decline of 2.7% from the year-ago numbers.

PepsiCo Inc. (PEP - Free Report) is one of the leading global food and beverage companies. The company currently carries a Zacks Rank #2.

The Zacks Consensus Estimate for PEP’s 2025 sales indicates growth of 1.7% from the previous year’s reported figures. PepsiCo has a trailing four-quarter average earnings surprise of 1.12%.

Ollie's Bargain Outlet (OLLI - Free Report) is a value retailer of brand-name merchandise at drastically reduced prices. It presently carries a Zacks Rank #2.

The Zacks Consensus Estimate for Ollie's 2025 sales and EPS indicates growth of 16.4% and 16.5%, respectively, from the prior-year reported levels. OLLI delivered a trailing four-quarter earnings surprise of 4.2%, on average.
2025-10-24 20:02 6mo ago
2025-10-24 15:46 6mo ago
Standard Uranium reports record grades at Corvo as exploration momentum builds – ICYMI stocknewsapi
STTDF
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) uncovered some of the highest uranium grades ever reported at its Corvo Project in Saskatchewan, signaling strong potential for future development.

Vice President of Exploration, Sean Hillacre, spoke with Proactive about the results, newly identified showings, and the company’s upcoming exploration plans.

Proactive: You’ve just reported some of the highest uranium grades ever recorded at the Corvo Project. What do these results tell you about the project’s potential, and how do they compare with historical findings in the area?

Sean Hillacre: That’s a great question. We’re really excited about what we’ve seen. We got boots on the ground earlier this summer for a prospecting, sampling, and mapping program, and the results have exceeded our expectations. Historically, the highest U₃O₈ grades at the Manhattan showing were around 7.2%, so we’re thrilled that we were able to sample the same area and return even higher values—up to 8.1% U₃O₈.

The rock types at Corvo look fantastic. As we mentioned in the release, we’re seeing a variety of rock types and deposit models, plus the added bonus of rare earth element concentrations. The geology is really interesting—seeing mineralized faults at surface and confirming those historical results is exceptional. We’re very excited to move the project forward and start drilling.

Your team also uncovered new radioactive showings and confirmed mineralization across multiple areas. Can you explain the geological significance of these discoveries and what makes Corvo such a promising uranium target?

That’s right. We identified several previously undocumented radioactive showings. The project saw a fair amount of exploration up until 1980, which was the last time it was drilled, and only limited modern work since then. So, being able to get out there and find numerous new showings across different rock types—pegmatite-hosted, metasedimentary-hosted, and gneiss-hosted uranium—is really exciting.

It speaks to the geological complexity of the area. We can clearly see the structural controls at surface, which is exactly what we’re looking for in a structurally and basement-hosted uranium system. The presence of radioactive boulders also reflects glacial transport and hints at multiple deposit types and mineralization zones across the project. All of that makes Corvo a very promising target.

You mentioned plans for a ground gravity survey in December and a drill program in early 2026. What are the key objectives of these programs, and what would success look like for Standard Uranium?

Since acquiring the project, we’ve partnered with Axiom Exploration, who flew a new electromagnetic survey earlier this year. That survey confirmed and extended the strike length of conductive zones—the plumbing system for uranium mineralization.

Now, the next step is to refine our drill targets through a gravity survey. Once the lakes freeze—likely by late November or early December—we’ll get crews on the ground to cover nearly 30 kilometers of strike length. The gravity data will help us identify alteration halos and density lows, which often correlate with uranium deposits or hydrothermal activity.

That information will allow us to pinpoint our first drill targets ahead of the initial drill program—the first on this property in about 40 years. Another advantage is infrastructure: the highway runs right through the southeastern corner of the project, so we’ll have excellent access and can keep drilling costs down. We’re really looking forward to testing these targets for the first time.

Quotes have been lightly edited for style and clarity
2025-10-24 20:02 6mo ago
2025-10-24 15:47 6mo ago
FIBRA Macquarie México (DBMBF) Q3 2025 Earnings Call Transcript stocknewsapi
DBMBF
FIBRA Macquarie México (OTC:DBMBF) Q3 2025 Earnings Call October 24, 2025 1:00 PM EDT

Company Participants

Nikki Sacks - Investor Relations Executive
Simon Hanna - Chief Executive Officer of Macquarie Asset Management México, S.A. de C.V.
Andrew McDonald-Hughes - Chief Financial Officer of Macquarie Asset Management México, S.A. de C.V.

Conference Call Participants

André Mazini - Citigroup Inc., Research Division
Wilfredo Jorel Guilloty - Goldman Sachs Group, Inc., Research Division
Alejandra Obregon - Morgan Stanley, Research Division
Alan Macias - BofA Securities, Research Division

Presentation

Operator

Good morning, and welcome to FIBRA Macquarie's Third Quarter 2025 Earnings Call and Webcast. My name is Rob, and I'll be your operator for this call. [Operator Instructions]

I would now like to turn the conference call over to Nikki Sacks. Please go ahead.

Nikki Sacks
Investor Relations Executive

Thank you, and good morning, everyone. Thank you for joining FIBRA Macquarie's third quarter 2025 earnings conference call and webcast. Today's call will be led by Simon Hanna, our Chief Executive Officer; and Andrew McDonald-Hughes, our CFO.

Before I turn the call over to Simon, I'd like to remind everyone that this presentation is proprietary, and all rights are reserved. The presentation has been prepared solely for informational purposes and is not a solicitation or an offer to buy or sell any securities. Forward-looking statements in this presentation are subject to a number of risks and uncertainties. Our actual results, performance, prospects or opportunities could differ materially from those expressed in or implied by the forward-looking statements.

These forward-looking statements are made as of the date of this presentation. We undertake no obligation to publicly update or revise any forward-looking statements after the completion of this presentation, whether as a result of new information, future events or otherwise, except as required by law.

Additionally, on this conference call, we may

Recommended For You
2025-10-24 20:02 6mo ago
2025-10-24 15:47 6mo ago
GoviEx Uranium securityholders approve proposed plan of arrangement with Tombador Iron stocknewsapi
GVXXF
GoviEx Uranium Inc (TSX-V:GXU, OTCQB:GVXXF) announced that its securityholders have voted overwhelmingly in favor of the company’s proposed plan of arrangement with Tombador Iron.

At a special meeting held on October 24, GoviEx shareholders, warrantholders, and optionholders approved the transaction, which will see Tombador acquire all issued and outstanding Class A common shares of GoviEx.

The deal will be completed through a court-approved plan of arrangement under the Business Corporations Act of British Columbia. 

Once completed, the transaction will create Atomic Eagle, an ASX-listed uranium-focused company that will advance GoviEx’s Muntanga Project in Zambia.

The special resolution required approval from at least two-thirds of the votes cast by both GoviEx shareholders and the combined securityholder group.

According to GoviEx, approximately 98.7% of votes cast by shareholders and 99.2% of votes cast by all securityholders supported the arrangement.

Tombador shareholders had previously approved their side of the transaction at a general meeting on October 8, including the issuance of consideration shares to GoviEx shareholders, replacement options to GoviEx optionholders and warrantholders, and a corporate name change to Atomic Eagle.

GoviEx said it will now seek final approval from the Supreme Court of British Columbia at a hearing scheduled for November 5, 2025.

Pending court and regulatory approvals, the companies expect the transaction to close in mid-November.
2025-10-24 20:02 6mo ago
2025-10-24 15:48 6mo ago
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit stocknewsapi
JSPR
, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.

So what: If you purchased Jasper Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Jasper Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=45109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (2) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of Jasper's products, including briquilimab; (3) the foregoing increased the likelihood of disruptive cost-reduction measures; (4) accordingly, Jasper's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Jasper Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=45109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-24 20:02 6mo ago
2025-10-24 15:51 6mo ago
Palantir Expands AI Alliance With Lumen for Enterprise Innovation stocknewsapi
PLTR
Key Takeaways Palantir expands its alliance with Lumen through a multi-year, multi-million-dollar AI partnership.The deal links Palantir's AI Platform with Lumen's Connectivity Fabric for faster, safer data integration.The collaboration boosts Palantir's commercial market presence while enhancing Lumen's AI capabilities.
Palantir Technologies (PLTR - Free Report) has deepened its collaboration with Lumen Technologies (LUMN - Free Report) through a multi-year, multi-million-dollar strategic partnership focused on helping enterprises deploy artificial intelligence faster and more securely.

The deal integrates Palantir’s Foundry and Artificial Intelligence Platform with Lumen’s Connectivity Fabric, designed to streamline data movement across multi-cloud environments. Together, the companies aim to simplify enterprise AI adoption while improving scalability, performance, and security.

For Palantir, the partnership reinforces its growing presence in commercial markets, extending its AI capabilities to global businesses. Lumen, meanwhile, strengthens its position as a next-generation digital networking provider. Although financial details remain undisclosed, both firms are positioning themselves to power enterprise-level AI transformation across industries.

Stocks to Watch: NVDA, MSFTNvidia (NVDA - Free Report) remains a cornerstone of the AI ecosystem, with its GPUs powering machine learning and data center growth. As enterprises accelerate AI deployment, NVDA’s technology is in constant demand. Nvidia continues to expand its product lineup and partnerships to stay ahead of competitors. For investors, Nvidia represents a long-term growth opportunity in the AI hardware and infrastructure market.

Microsoft (MSFT - Free Report) continues to lead in AI integration through Azure and its productivity tools. With the rapid adoption of Copilot and strong cloud momentum, Microsoft is cementing its role as an enterprise AI leader. Microsoft’s investments in AI partnerships and infrastructure signal confidence in sustained demand. For investors seeking diversified AI exposure, MSFT remains a reliable long-term play.

PLTR’s Price Performance, EstimatesThe stock has surged a whopping 139% year to date, significantly outperforming the industry’s 19% rally.

                                               Image Source: Zacks Investment Research

From a valuation standpoint, PLTR trades at a forward price-to-sales ratio of 80X, well above the industry’s 5.6X. It carries a Value Score of F.

                                                              Image Source: Zacks Investment Research

The Zacks Consensus Estimate for PLTR’s 2025 earnings remained unchanged over the past 30 days.

                                                              Image Source: Zacks Investment Research

PLTR stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-10-24 20:02 6mo ago
2025-10-24 15:55 6mo ago
Uniserve first quarter results for the period ended August 31, 2025 stocknewsapi
USSHF
Vancouver, BC:  October 24, 2025 – TheNewswire - Uniserve Communications Corporation (the “Company” or “Uniserve”)(TSXV: USS)  a provider of IT solutions and services to business and residential customers in Canada wishes to announce first quarter fiscal 2026 financial results. Q1 fiscal 2026 revenues were $2,122K as compared to $1,651K for the same period in the prior fiscal year. Q1 fiscal 2026 Net Loss was $264K as compared to Net loss of $112K for the same prior year fiscal period. The Company will continue to focus on its operating results in fiscal 2026 by continuing to implement operational efficiencies, grow recurring revenues and enhance value added for its customers.

About Uniserve

Currently based in Vancouver, Calgary and Waterloo, the Company provides smart technology solutions and reliable services for home and business customers.  These services include a full range of IT services from e-mail and voice to fully managed turnkey solutions.  Uniserve offers products across three verticals: Residential, Small Business and Enterprise. For residential customers, the Company offers telecommunications, and high-speed internet services. For small business, the Company offers technology bundles for start-ups, professionals, creative industries, and retail outlets. For enterprise customers, the Company can deliver leading-edge, comprehensive managed IT services with a focus on security, business continuity, communications, disaster recovery, cloud and application hosting, all backed with 24/7 technical support based in Canada. The Company has its own T2 data centre in Vancouver, B.C. (with backup / disaster recovery, and failover in Calgary).

This news release was prepared on behalf of the Board of Directors, which accepts full responsibility for its contents.

Learn more at www.uniserve.com or at www.sedar.com.

Kwin Grauer

Interim CEO

For more information please call 604-395-3961 or email [email protected].

Neither TSX Venture Exchange nor its Regulations Services Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Management has prepared this release and no regulatory authority has approved or disapproved the information contained herein. The statements contained in this news release that are not historical facts are forward looking statements. Such statements are based on management’s estimates, assumptions and projections using available information. Uniserve cautions that actual financial results could differ materially from the current expectations due to a number of factors.

 
2025-10-24 20:02 6mo ago
2025-10-24 15:56 6mo ago
Kellanova Declares Regular Dividend of $0.58 per Share for Fourth Quarter stocknewsapi
K
, /PRNewswire/ -- Kellanova (NYSE: K) today announced that its Board of Directors declared a dividend of $0.58 per share on the common stock of Kellanova, payable on December 15, 2025, to shareowners of record at the close of business on December 1, 2025. The ex-dividend date is December 1, 2025.  This is the 404th dividend that Kellanova has paid to owners of common stock since 1925.

About Kellanova

Kellanova (NYSE: K) is a leader in global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching back more than 100 years. Powered by differentiated brands including Pringles®, Cheez-It®, Pop-Tarts®, Kellogg's ® Rice Krispies Treats®, RXBAR®, Eggo®, MorningStar Farms®, Special K®, Coco Pops®, and more, Kellanova's vision is to become the world's best-performing snacks-led powerhouse, unleashing the full potential of our differentiated brands and our passionate people. Our net sales for 2024 were approximately $13 billion.

At Kellanova, our purpose is to create better days and ensure everyone has a seat at the table through our trusted food brands. We are committed to promoting sustainable and equitable food access by tackling the crossroads of hunger, sustainability, wellbeing, and equity, diversity & inclusion. Our goal is to create Better Days for 4 billion people by the end of 2030 (from a 2015 baseline). For more detailed information about our commitments, our approach to achieving these goals, and methodology, please visit our website at https://www.kellanova.com.

[K-DIV] [K-FIN]

SOURCE Kellanova IR

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In